10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 1, 2016.

OR

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                                  to                                                

Commission file number 1-7685

AVERY DENNISON CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	95-1492269
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)
207 Goode Avenue Glendale, California	91203
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (626) 304-2000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

x Large accelerated filer	o Accelerated filer	o Non-accelerated filer	o Smaller reporting company
	(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

Number of shares of $1 par value common stock outstanding as of October 29, 2016: 88,991,587

AVERY DENNISON CORPORATION

FISCAL THIRD QUARTER 2016 QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page
SAFE HARBOR STATEMENT		1
PART I. FINANCIAL INFORMATION (UNAUDITED)
Item 1.	Financial Statements:
	Condensed Consolidated Balance Sheets October 1, 2016 and January 2, 2016	2
	Condensed Consolidated Statements of Income Three and Nine Months ended October 1, 2016 and October 3, 2015	3
	Condensed Consolidated Statements of Comprehensive Income Three and Nine Months ended October 1, 2016 and October 3, 2015	4
	Condensed Consolidated Statements of Cash Flows Three and Nine Months ended October 1, 2016 and October 3, 2015	5
	Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
	Non-GAAP Financial Measures	19
	Overview and Outlook	20
	Analysis of Results of Operations for the Third Quarter	22
	Results of Operations by Reportable Segment for the Third Quarter	23
	Analysis of Results of Operations for the Nine Months Year-to-Date	25
	Results of Operations by Reportable Segment for the Nine Months Year-to-Date	27
	Financial Condition	29
	Recent Accounting Requirements	32
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	33
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3.	Defaults Upon Senior Securities	34
Item 4.	Mine Safety Disclosures	34
Item 5.	Other Information	35
Item 6.	Exhibits	35
Signatures		36
Exhibits

SAFE HARBOR STATEMENT

The matters discussed in this Quarterly Report contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “foresee,” “guidance,” “intend,” “may,” “might,” “objective,” “plan,” “potential,” “project,” “seek,” “shall,” “should,” “target,” “will,” “would,” or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.

Certain risks and uncertainties are discussed in more detail under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended January 2, 2016, and subsequent quarterly reports on Form 10-Q, and include, but are not limited to, risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; worldwide and local economic conditions; fluctuations in currency exchange rates and other risks associated with foreign operations, including in emerging markets; the financial condition and inventory strategies of customers; changes in customer preferences; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; the impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; fluctuations in pension, insurance, and employee benefit costs; the impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; protection and infringement of intellectual property; changes in political conditions; the impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.

We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impacts of economic conditions on underlying demand for our products and foreign currency fluctuations; (2) competitors’ actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume.

Our forward-looking statements are made only as of the date hereof.  We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.

1

Avery Dennison Corporation

PART I. FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Dollars in millions, except per share amount)	October 1, 2016			January 2, 2016
Assets
Current assets:
Cash and cash equivalents	$	189.4		$	158.8
Trade accounts receivable, less allowances of $40.6 and $31.5 at October 1, 2016 and January 2, 2016, respectively	1,069.7			964.7
Inventories, net	565.3			478.7
Assets held for sale	5.9			2.5
Other current assets	183.3			170.7
Total current assets	2,013.6			1,775.4
Property, plant and equipment	2,685.5			2,599.9
Accumulated depreciation	(1,780.1		)	(1,752.0		)
Property, plant and equipment, net	905.4			847.9
Goodwill	821.6			686.2
Other intangibles resulting from business acquisitions, net	70.9			45.8
Non-current deferred income taxes	390.7			372.2
Other assets	398.2			406.2
	$	4,600.4		$	4,133.7
Liabilities and Shareholders’ Equity
Current liabilities:
Short-term borrowings and current portion of long-term debt and capital leases	$	587.6		$	95.3
Accounts payable	866.7			814.6
Accrued payroll and employee benefits	207.8			194.6
Other current liabilities	394.0			354.6
Total current liabilities	2,056.1			1,459.1
Long-term debt and capital leases	713.0			963.6
Long-term retirement benefits and other liabilities	684.5			637.4
Non-current deferred and payable income taxes	104.4			107.9
Commitments and contingencies (see Note 15)
Shareholders’ equity:
Common stock, $1 par value per share, authorized — 400,000,000 shares at October 1, 2016 and January 2, 2016; issued — 124,126,624 shares at October 1, 2016 and January 2, 2016; outstanding — 89,194,833 shares and 89,967,697 shares at October 1, 2016 and January 2, 2016, respectively	124.1			124.1
Capital in excess of par value	843.1			834.0
Retained earnings	2,444.1			2,277.6
Treasury stock at cost, 34,931,791 shares and 34,158,927 shares at October 1, 2016 and January 2, 2016, respectively	(1,699.9		)	(1,587.0		)
Accumulated other comprehensive loss	(669.0		)	(683.0		)
Total shareholders’ equity	1,042.4			965.7
	$	4,600.4		$	4,133.7

See Notes to Unaudited Condensed Consolidated Financial Statements

2

Avery Dennison Corporation

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

	Three Months Ended				Nine Months Ended
(In millions, except per share amounts)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
Net sales	$	1,508.7	$	1,468.1	$	4,535.7	$	4,512.1
Cost of products sold	1,091.1		1,062.2		3,261.4		3,258.6
Gross profit	417.6		405.9		1,274.3		1,253.5
Marketing, general and administrative expense	270.3		268.1		817.7		841.8
Interest expense	14.7		14.7		45.4		45.3
Other expense, net	4.6		7.0		60.4		49.0
Income from continuing operations before taxes	128.0		116.1		350.8		317.4
Provision for income taxes	38.9		34.8		92.1		99.5
Income from continuing operations	89.1		81.3		258.7		217.9
Income (loss) from discontinued operations	–		.4		–		(.6		)
Net income	$	89.1	$	81.7	$	258.7	$	217.3
Per share amounts:
Net income per common share:
Continuing operations	$	1.00	$	.89	$	2.90	$	2.39
Discontinued operations	–		–		–		–
Net income per common share	$	1.00	$	.89	$	2.90	$	2.39
Net income (loss) per common share, assuming dilution:
Continuing operations	$	.98	$	.87	$	2.85	$	2.35
Discontinued operations	–		.01		–		(.01		)
Net income per common share, assuming dilution	$	.98	$	.88	$	2.85	$	2.34
Dividends per common share	$	.41	$	.37	$	1.19	$	1.09
Weighted average number of shares outstanding:
Common shares	89.1		91.5		89.2		91.1
Common shares, assuming dilution	90.6		93.2		90.9		92.9

See Notes to Unaudited Condensed Consolidated Financial Statements

3

Avery Dennison Corporation

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Net income	$	89.1		$	81.7		$	258.7		$	217.3
Other comprehensive income (loss), net of tax:
Foreign currency translation	15.5			(60.5		)	21.1			(129.6		)
Pension and other postretirement benefits	4.4			5.1			(6.9		)	17.7
Cash flow hedges	(.1		)	(.2		)	(.2		)	(.8		)
Other comprehensive income (loss), net of tax	19.8			(55.6		)	14.0			(112.7		)
Total comprehensive income, net of tax	$	108.9		$	26.1		$	272.7		$	104.6

See Notes to Unaudited Condensed Consolidated Financial Statements

4

Avery Dennison Corporation

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Operating Activities
Net income	$	258.7		$	217.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	88.8			95.3
Amortization	46.7			47.5
Provision for doubtful accounts and sales returns	33.8			36.6
Net losses from asset impairments and sales/disposals of assets	3.8			10.9
Stock-based compensation	20.1			18.4
Loss from settlement of pension obligations	41.4			–
Other non-cash expense and loss	34.7			38.9
Changes in assets and liabilities and other adjustments	(162.3		)	(182.7		)
Net cash provided by operating activities	365.7			282.2
Investing Activities
Purchases of property, plant and equipment	(104.9		)	(89.6		)
Purchases of software and other deferred charges	(16.6		)	(9.0		)
Proceeds from sales of property, plant and equipment	4.3			7.1
Purchases of investments, net	(.8		)	(.2		)
Payments for acquisitions, net of cash acquired	(227.5		)	–
Other	–			1.5
Net cash used in investing activities	(345.5		)	(90.2		)
Financing Activities
Net increase (decrease) in borrowings (maturities of three months or less)	242.0			(109.8		)
Payments of debt (maturities greater than three months)	(1.9		)	(6.2		)
Dividends paid	(106.2		)	(99.6		)
Share repurchases	(181.5		)	(108.5		)
Proceeds from exercises of stock options, net	63.4			78.4
Other	(4.4		)	(1.2		)
Net cash provided by (used in) financing activities	11.4			(246.9		)
Effect of foreign currency translation on cash balances	(1.0		)	(8.5		)
Increase (decrease) in cash and cash equivalents	30.6			(63.4		)
Cash and cash equivalents, beginning of year	158.8			207.2
Cash and cash equivalents, end of period	$	189.4		$	143.8

See Notes to Unaudited Condensed Consolidated Financial Statements

5

Avery Dennison Corporation

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1.  General

The unaudited Condensed Consolidated Financial Statements and notes in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and notes thereto in our 2015 Annual Report on Form 10-K, which should be read in conjunction with this Quarterly Report on Form 10-Q. The accompanying unaudited Condensed Consolidated Financial Statements include normal recurring adjustments necessary for a fair statement of our interim results.  Interim results of operations are not necessarily indicative of future results.

Fiscal Periods

The third quarters of 2016 and 2015 consisted of thirteen-week periods ending October 1, 2016 and October 3, 2015, respectively. The nine months ended October 1, 2016 and October 3, 2015 each consisted of thirty-nine-week periods.

Prior Period Financial Statement Revision

In the fourth quarter of 2015, we identified certain liquid short-term bank drafts with maturities greater than three months that were improperly classified as cash and cash equivalents instead of other current assets, which resulted in an overstatement of operating cash flows, and tax effects related to certain foreign pension plans that were not properly accounted for in our consolidated financial statements. We assessed the materiality of these errors on our financial statements for prior periods in accordance with United States Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 99, Materiality, codified in Accounting Standards Codification (“ASC”) 250, Presentation of Financial Statements, and concluded that they were not material to any prior annual or interim periods.  Consequently, in accordance with ASC 250 (SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements), we corrected these errors for all prior periods presented by revising the unaudited Condensed Consolidated Financial Statements and other financial information included herein.

The effects of the revision on our unaudited Condensed Consolidated Statements of Cash Flows were as follows:

	Nine Months Ended October 3, 2015
(In millions)	As Previously Reported			Adjustment			As Revised
Net cash provided by operating activities	$	290.3		$	(8.1	)	$	282.2
Decrease in cash and cash equivalents	(55.3		)	(8.1		)	(63.4		)
Cash and cash equivalents, beginning of year	227.0			(19.8		)	207.2
Cash and cash equivalents, end of period	171.7			(27.9		)	143.8

Sale of Product Line

In May 2015, we sold certain assets and transferred certain liabilities associated with a product line in our Retail Branding and Information Solutions (“RBIS”) reportable segment for $1.5 million.  The pre-tax loss from the sale, when combined with exit costs related to the sale, totaled $8.5 million. In the first quarter of 2015, we recorded an impairment charge of approximately $2 million related to certain long-lived assets of this product line, as well as $.6 million of other costs related to this sale. This loss and these costs were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

Discontinued Operations

Income (loss) from discontinued operations during the third quarter and nine months ended October 3, 2015 included tax benefits (expense) related to the completion of certain tax return filings related to the sale of our former Office and Consumer Products (“OCP”) and Designed and Engineered Solutions (“DES”) businesses. We continue to be subject to certain indemnification obligations under the terms of the purchase agreement. In addition, the tax liability associated with the sale remains subject to the completion of tax return filings in certain foreign jurisdictions where we formerly operated the OCP and DES businesses.

Note 2. Acquisitions

On August 1, 2016, we completed the acquisition of the European business of MACtac (“Mactac”) from Platinum Equity through the purchase of Evergreen Holding V, LLC. Mactac manufactures pressure-sensitive materials that complement our existing graphics portfolio and has been included in our Pressure-sensitive Materials segment. The total consideration for this acquisition, net of cash received, was approximately $222 million, which we funded primarily through existing credit facilities. The purchase price is subject to certain adjustments in accordance with the terms of the purchase agreement

6

Avery Dennison Corporation

Due to the time required to complete our assessment, the final valuation of certain acquired assets and liabilities, including property, plant and equipment, intangible assets, taxes, and environmental and asset retirement obligations, is currently pending.

This acquisition was not material to our condensed consolidated financial statements.

Note 3.  Inventories

Net inventories consisted of:

(In millions)	October 1, 2016		January 2, 2016
Raw materials	$	207.8	$	180.5
Work-in-progress	172.1		143.0
Finished goods	185.4		155.2
Inventories, net	$	565.3	$	478.7

Note 4.  Goodwill and Other Intangibles Resulting from Business Acquisitions

Goodwill

Changes in the net carrying amount of goodwill for the nine months ended October 1, 2016, by reportable segment, were as follows:

(In millions)	Pressure-sensitive Materials		Retail Branding and Information Solutions		Total
Goodwill as of January 2, 2016	$	277.9	$	408.3	$	686.2
Acquired during current period(1)	125.0		–		125.0
Translation adjustments	7.2		3.2		10.4
Goodwill as of October 1, 2016	$	410.1	$	411.5	$	821.6

(1) Goodwill acquired during the current period primarily related to the Mactac acquisition.

The carrying amounts of goodwill at October 1, 2016 and January 2, 2016 were net of accumulated impairment losses of $820 million, which were included in our RBIS reportable segment.

There was no goodwill associated with our Vancive Medical Technologies reportable segment.

In connection with the Mactac acquisition, we recognized an estimated $120 million of preliminary goodwill based on our expectation of synergies and other benefits of combining our businesses. These synergies and benefits include use of our existing commercial infrastructure to expand sales of products of the acquired business in a cost-efficient manner. The amount of goodwill recognized is not expected to be deductible for tax purposes.

Other Intangibles Resulting from Business Acquisitions

In connection with the Mactac acquisition, we acquired approximately $39 million of identifiable intangible assets, which includes finite-lived and indefinite-lived intangible assets. Identifiable intangible assets consist of customer relationships, trade names and trademarks, and patents and other acquired technology.  The table below summarizes the preliminary amounts and weighted average useful lives, if applicable, of these intangible assets:

	Amount (in millions)		Weighted-average amortization period (in years)
Customer relationships	$	22.8		15
Patents and other acquired technology	2.4		4
Trade names and trademarks(1)	14.2		n/a

(1) Acquired trade names and trademarks associated with the Mactac acquisition were not subject to amortization as they were classified as indefinite-lived intangible assets.

7

Avery Dennison Corporation

Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

Note 5.  Debt and Capital Leases

The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities on notes with similar rates, credit ratings, and remaining maturities. The fair value of short-term borrowings, which includes commercial paper issuances and short-term lines of credit, approximates carrying value given the short duration of these obligations.  The fair value of our total debt was $1.35 billion at October 1, 2016 and $1.08 billion at January 2, 2016. Fair value amounts were determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable.

Our $700 million revolving credit facility (the “Revolver”) contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of October 1, 2016 and January 2, 2016, we were in compliance with our financial covenants.

In March 2016, we entered into an agreement with three commercial paper dealers to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Proceeds from issuances under this program may be used for general corporate purposes. The maturities of the notes may vary, but may not exceed 364 days from the date of issuance. Our payment obligations with respect to any notes issued under this program would be backed by the Revolver. There are no financial covenants under this program. As of October 1, 2016, $210.3 million was outstanding under this program.

We reclassified approximately $250 million of senior notes due on October 1, 2017 from long-term debt to current portion of long-term debt.

Note 6.  Pension and Other Postretirement Benefits

Defined Benefit Plans

We sponsor a number of defined benefit plans, the accrual of benefits under some of which has been frozen, covering eligible employees in the U.S. and certain other countries.  Benefits payable to an employee are based primarily on years of service and the employee’s compensation during the course of his or her employment with us.

We are also obligated to pay unfunded termination indemnity benefits to certain employees outside of the U.S., which are subject to applicable agreements, laws and regulations.  We have not incurred significant costs related to these benefits, and therefore, no related costs are included in the disclosures below.

In December 2015, we offered eligible former employees who were vested participants in the Avery Dennison Pension Plan (“ADPP”), a U.S. pension plan, the opportunity to receive their benefits immediately as either a lump-sum payment or an annuity, rather than waiting until they are retirement eligible under the terms of the plan. In the second quarter of 2016, approximately $70 million of pension obligations related to this plan were settled out of existing plan assets and a non-cash pre-tax settlement charge of $41.4 million was recorded in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.  This settlement required us to remeasure the remaining net pension obligations of the ADPP. As a result, approximately $72 million of additional net pension obligations with a corresponding increase in actuarial losses recorded in “Accumulated other comprehensive loss” was recognized primarily due to lower discount rates that were in effect when the plan was remeasured.

8

Avery Dennison Corporation

The following table sets forth the components of net periodic benefit cost (credit), which was recorded in income from continuing operations, for our defined benefit plans:

	Pension Benefits
	Three Months Ended												Nine Months Ended
	October 1, 2016						October 3, 2015						October 1, 2016						October 3, 2015
(In millions)	U.S.			Int’l			U.S.			Int’l			U.S.			Int’l			U.S.			Int’l
Service cost	$	.1		$	3.5		$	.1		$	3.3		$	.3		$	10.4		$	.3		$	10.3
Interest cost	8.1			4.1			10.8			4.3			26.4			12.4			32.5			13.1
Actuarial loss	.7			–			–			–			2.4			–			–			–
Expected return on plan assets	(10.4		)	(5.4		)	(12.8		)	(5.4		)	(32.3		)	(16.1		)	(38.6		)	(16.2		)
Recognized net actuarial loss	4.9			1.7			5.2			2.4			14.1			5.3			15.4			7.2
Amortization of prior service cost (credit)	.3			–			.2			–			.9			(.2		)	.8			(.1		)
Recognized loss on settlements(1)	–			–			–			–			41.4			–			–			3.8
Net periodic benefit cost	$	3.7		$	3.9		$	3.5		$	4.6		$	53.2		$	11.8		$	10.4		$	18.1

 (1)In 2016, we recognized a loss on settlements related to our U.S. pension plan as a result of making the lump-sum pension payments described above; in 2015, we recognized a loss on settlements related to pension plans in Germany and France as a result of the sale of a product line in our RBIS reportable segment.  These losses on settlements were recorded in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

	U.S. Postretirement Health Benefits
	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Interest cost	$	–		$	.1		$	.1		$	.2
Recognized net actuarial loss	.5			.5			1.3			1.6
Amortization of prior service credit	(.9		)	(.8		)	(2.5		)	(2.4		)
Net periodic benefit credit	$	(.4	)	$	(.2	)	$	(1.1	)	$	(.6	)

Note 7.  Research and Development

Research and development expense from continuing operations was $22.4 million and $67.4 million for the three and nine months ended October 1, 2016, respectively, and $22.2 million and $70.6 million for the three and nine months ended October 3, 2015, respectively. This expense was included in “Marketing, general and administrative expense” in the unaudited Condensed Consolidated Statements of Income.

Note 8.  Long-Term Incentive Compensation

Equity Awards

Stock-based compensation expense from continuing operations was $6 million and $20.1 million for the three and nine months ended October 1, 2016, respectively, and $5.2 million and $18.4 million for the three and nine months ended October 3, 2015, respectively.  This expense was included in “Marketing, general and administrative expense” in the unaudited Condensed Consolidated Statements of Income.

As of October 1, 2016, we had approximately $44 million of unrecognized compensation expense from continuing operations related to unvested stock-based awards, which is expected to be recognized over the remaining weighted-average period of approximately two years.

Cash Awards

Compensation expense from continuing operations related to long-term incentive units was $7 million and $21.7 million for the three and nine months ended October 1, 2016, respectively, and $1.4 million and $16.7 million for the three and nine months ended October 3, 2015, respectively. This expense was included in “Marketing, general and administrative expense” in the unaudited Condensed Consolidated Statements of Income.

9

Avery Dennison Corporation

Note 9.  Cost Reduction Actions

2015/2016 Actions

During the nine months ended October 1, 2016, we recorded $15 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015 that we expect to continue through 2016 (“2015/2016 Actions”). These charges consisted of severance and related costs for the reduction of approximately 310 positions, lease cancellation costs, and asset impairment charges.

During fiscal year 2015, we recorded $26.1 million in restructuring charges, net of reversals, related to our 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 430 positions, lease cancellation costs, and asset impairment charges.

No employees impacted by our 2015/2016 Actions taken through October 1, 2016 remained employed with us as of such date. We expect charges and payments related to these actions to be substantially completed in 2016.

2014/2015 Actions

During fiscal year 2015, we recorded $33.4 million in restructuring charges, net of reversals, related to restructuring actions we initiated in 2014 that continued through the second quarter of 2015 (“2014/2015 Actions”). These charges consisted of severance and related costs for the reduction of approximately 605 positions, lease cancellation costs, and asset impairment charges.

Approximately 25 employees impacted by our 2014/2015 Actions remained employed with us as of October 1, 2016. We expect charges and payments related to these actions to be substantially completed in 2016.

Accruals for severance and related costs and lease cancellation costs were included in “Other current liabilities” in the unaudited Condensed Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets, less selling costs, if applicable.  Restructuring charges were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

During the nine months ended October 1, 2016, restructuring charges and payments were as follows:

(In millions)	Accrual at January 2, 2016		Charges (Reversals), net			Cash Payments			Non-cash Impairment			Foreign Currency Translation		Accrual at October 1, 2016
2015/2016 Actions
Severance and related costs	$	8.4	$	11.1		$	(18.8	)	$	–		$	.2	$	.9
Asset impairment charges	–		2.9			–			(2.9		)	–		–
Lease cancellation costs	.2		1.0			(.8		)	–			–		.4
2014/2015 Actions
Severance and related costs	4.8		(.3		)	(3.3		)	–			–		1.2
Prior actions
Severance and related costs	.7		(.1		)	–			–			–		.6
Total	$	14.1	$	14.6		$	(22.9	)	$	(2.9	)	$	.2	$	3.1

10

Avery Dennison Corporation

The table below shows the total amount of restructuring charges incurred by reportable segment and Corporate:

	Three Months Ended				Nine Months Ended
(In millions)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
Restructuring charges by reportable segment and Corporate
Pressure-sensitive Materials	$	.7	$	1.1	$	7.5	$	15.5
Retail Branding and Information Solutions	1.5		3.7		6.6		19.4
Vancive Medical Technologies	.4		1.7		.5		3.4
Corporate	–		.1		–		2.2
	$	2.6	$	6.6	$	14.6	$	40.5

Note 10.  Financial Instruments

We enter into foreign exchange hedge contracts to reduce our risk from exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S.  We enter into interest rate contracts to help manage our exposure to certain interest rate fluctuations.  We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The maximum length of time for which we hedge our exposure to the variability in future cash flows for forecasted transactions is 36 months.

As of October 1, 2016, the aggregate U.S. dollar equivalent notional value of our outstanding commodity contracts and foreign exchange contracts was $2.3 million and $1.5 billion, respectively.

We recognize all derivative instruments as either assets or liabilities at fair value in the unaudited Condensed Consolidated Balance Sheets. We designate commodity forward contracts on forecasted purchases of commodities and foreign exchange contracts on forecasted transactions as cash flow hedges and designate foreign exchange contracts on existing balance sheet items as fair value hedges.

The following table provides the fair value and balance sheet locations of derivatives as of October 1, 2016:

	Asset			Liability
(In millions)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Other current assets	$	2.0	Other current liabilities	$	3.1
Commodity contracts	Other current assets	.1		Other current liabilities	–
		$	2.1		$	3.1

The following table provides the fair value and balance sheet locations of derivatives as of January 2, 2016:

	Asset			Liability
(In millions)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Other current assets	$	5.6	Other current liabilities	$	4.5
Commodity contracts	Other current assets	–		Other current liabilities	.7
		$	5.6		$	5.2

Fair Value Hedges

For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings, resulting in no material net impact to income.

11

Avery Dennison Corporation

The following table provides the components of net gains (losses) recognized in income related to fair value hedge contracts. The corresponding gains or losses on the underlying hedged items approximated the net gains (losses) on these fair value hedge contracts.

		Three Months Ended						Nine Months Ended
(In millions)	Location of Net Gains (Losses) in Income	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Foreign exchange contracts	Cost of products sold	$	(.2	)	$	2.3		$	1.5		$	3.3
Foreign exchange contracts	Marketing, general and administrative expense	(2.8		)	(19.9		)	(.4		)	(15.9		)
		$	(3.0	)	$	(17.6	)	$	1.1		$	(12.6	)

Cash Flow Hedges

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of “Accumulated other comprehensive loss” and reclassified into earnings in the same period(s) during which the hedged transaction impacts earnings.  Gains and losses on the derivative, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in current earnings.

Gains (losses) recognized in “Accumulated other comprehensive loss” (effective portion) on derivatives related to cash flow hedge contracts were as follows:

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Foreign exchange contracts	$	(1.3	)	$	2.7		$	(3.1	)	$	1.2
Commodity contracts	(.2		)	(1.7		)	.1			(.5		)
	$	(1.5	)	$	1.0		$	(3.0	)	$	.7

The amount of gain or loss recognized in income related to the ineffective portion of, and the amount excluded from, effectiveness testing for cash flow hedges and derivatives not designated as hedging instruments was not material for the three and nine months ended October 1, 2016 and October 3, 2015, respectively.

As of October 1, 2016, we expected a net loss of approximately $2 million to be reclassified from “Accumulated other comprehensive loss” to earnings within the next 12 months.  See Note 13, “Comprehensive Income,” for more information.

Note 11.  Taxes Based on Income

The following table summarizes our income from continuing operations before taxes, provision for income taxes from continuing operations, and effective tax rate:

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Provision for income taxes	38.9			34.8			92.1			99.5
Effective tax rate	30.4		%	30.0		%	26.3		%	31.3		%

The effective tax rate for continuing operations for the three and nine months ended October 1, 2016 reflected the impact of favorable geographic mixture of pretax income and included the following: $4.8 million and $3.1 million of tax expense, respectively, resulting from return to provision adjustments pursuant to the completion of the 2015 U.S. federal tax return; $1 million and $7.1 million of tax benefit, respectively, from our change in judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; and $17.7 million and $26.9 million of tax expense, respectively, associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries. The effective tax rate for the three and nine months ended October 1, 2016 also included $11.1 million of tax benefit resulting from effective settlements of tax examinations in various foreign jurisdictions.  Included in the $11.1 million of tax benefit is an effective settlement for certain members of a consolidated tax group under examination. Additionally, the effective tax rate for the nine months ended October 1, 2016 included $6.7 million of tax benefit from the release of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority and $3.3 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years.

12

Avery Dennison Corporation

The effective tax rate for the nine months ended October 1, 2016 compared to the effective tax rate for the nine months ended October 3, 2015 was impacted by favorable effective settlements in various foreign jurisdictions, favorable geographic mixture of pretax income, and a tax benefit from the release of valuation allowances against deferred tax assets.

The effective tax rate for continuing operations for the three and nine months ended October 3, 2015 included $4.2 million of tax benefit resulting from return to provision adjustments pursuant to the completion of the 2014 U.S. federal tax return and $.9 million of tax benefit from a favorable foreign tax law change.  Additionally, the effective tax rate for the nine months ended October 3, 2015 included $1.6 million of net tax benefit related to changes in the effective tax rates in certain foreign municipalities; $4.2 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years; and $5.4 million of tax expense associated with the tax cost to repatriate non-permanently reinvested 2015 earnings of certain foreign subsidiaries.

The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world.  Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts, and circumstances existing at the time.  We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters.  However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate.  With some exceptions, we and our subsidiaries are no longer subject to income tax examinations by tax authorities for years prior to 2006.

It is reasonably possible that, during the next 12 months, we may realize a decrease in our uncertain tax positions, including interest and penalties, of approximately $26 million, primarily as a result of audit settlements and closing tax years.

Note 12.  Net Income Per Common Share

Net income per common share was computed as follows:

	Three Months Ended				Nine Months Ended
(In millions, except per share amounts)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
(A) Income from continuing operations	$	89.1	$	81.3	$	258.7	$	217.9
(B) Income (loss) from discontinued operations	–		.4		–		(.6		)
(C) Net income available to common shareholders	$	89.1	$	81.7	$	258.7	$	217.3
(D) Weighted average number of common shares outstanding	89.1		91.5		89.2		91.1
Dilutive shares (additional common shares issuable under stock-based awards)	1.5		1.7		1.7		1.8
(E) Weighted average number of common shares outstanding, assuming dilution	90.6		93.2		90.9		92.9
Net income per common share:
Continuing operations (A) ÷ (D)	$	1.00	$	.89	$	2.90	$	2.39
Discontinued operations (B) ÷ (D)	–		–		–		–
Net income per common share (C) ÷ (D)	$	1.00	$	.89	$	2.90	$	2.39
Net income (loss) per common share, assuming dilution:
Continuing operations (A) ÷ (E)	$	.98	$	.87	$	2.85	$	2.35
Discontinued operations (B) ÷ (E)	–		.01		–		(.01		)
Net income per common share, assuming dilution (C) ÷ (E)	$	.98	$	.88	$	2.85	$	2.34

Certain stock-based compensation awards were not included in the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation totaled approximately .1 million shares and .2 million shares for the three and nine months ended October 1, 2016, respectively, and approximately .5 million and 1 million shares for the three and nine months ended October 3, 2015, respectively.

13

Avery Dennison Corporation

Note 13.  Comprehensive Income

The changes in “Accumulated other comprehensive loss” (net of tax) for the nine months ended October 1, 2016 were as follows:

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total
Balance as of January 2, 2016	$	(158.9	)	$	(521.6	)	$	(2.5	)	$	(683.0	)
Other comprehensive income (loss) before reclassifications, net of tax	21.1			(46.7		)	(2.2		)	(27.8		)
Reclassifications to net income, net of tax	–			39.8			2.0			41.8
Net current-period other comprehensive income (loss), net of tax	21.1			(6.9		)	(.2		)	14.0
Balance as of October 1, 2016	$	(137.8	)	$	(528.5	)	$	(2.7	)	$	(669.0	)

The changes in “Accumulated other comprehensive loss” (net of tax) for the nine months ended October 3, 2015 were as follows:

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total
Balance as of January 3, 2015	$	(19.9	)	$	(525.6	)	$	–		$	(545.5	)
Other comprehensive (loss) income before reclassifications, net of tax	(129.6		)	(.5		)	.6			(129.5		)
Reclassifications to net income, net of tax	–			18.2			(1.4		)	16.8
Net current-period other comprehensive (loss) income, net of tax	(129.6		)	17.7			(.8		)	(112.7		)
Balance as of October 3, 2015	$	(149.5	)	$	(507.9	)	$	(.8	)	$	(658.2	)

The amounts reclassified from “Accumulated other comprehensive loss” to increase (decrease) income from continuing operations were as follows:

	Amounts Reclassified from Accumulated Other Comprehensive Loss
	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015			Affected Line Item in the Statements Where Net Income is Presented
Cash flow hedges:
Foreign exchange contracts	$	(1.2	)	$	1.4		$	(2.1	)	$	2.7		Cost of products sold
Commodity contracts	–			(.1		)	(.6		)	(.9		)	Cost of products sold
Interest rate contracts	(.1		)	(.1		)	(.1		)	(.1		)	Interest expense
	(1.3		)	1.2			(2.8		)	1.7			Total before tax
	.4			(.2		)	.8			(.3		)	Provision for income taxes
	(.9		)	1.0			(2.0		)	1.4			Net of tax
Pension and other postretirement benefits(1)	(6.5		)	(7.5		)	(60.3		)	(26.3		)
	2.1			2.4			20.5			8.1			Provision for income taxes
	(4.4		)	(5.1		)	(39.8		)	(18.2		)	Net of tax
Total reclassifications for the period	$	(5.3	)	$	(4.1	)	$	(41.8	)	$	(16.8	)	Total, net of tax

(1)See Note 6, “Pension and Other Postretirement Benefits,” for more information.

14

Avery Dennison Corporation

The following table sets forth the income tax expense (benefit) allocated to each component of other comprehensive income (loss):

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Pension and other postretirement benefits	$	2.0		$	2.4		$	(4.7	)	$	9.1
Cash flow hedges	(.1		)	(.1		)	–			(.2		)
Income tax expense (benefit) related to components of other comprehensive income (loss)	$	1.9		$	2.3		$	(4.7	)	$	8.9

Note 14.  Fair Value Measurements

Recurring Fair Value Measurements

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of October 1, 2016:

			Fair Value Measurements Using
(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets
Trading securities	$	18.9	$	12.7	$	6.2	$	–
Derivative assets	2.1		.1		2.0		–
Bank drafts	15.9		15.9		–		–
Liabilities
Derivative liabilities	$	3.1	$	–	$	3.1	$	–

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of January 2, 2016:

			Fair Value Measurements Using
(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets
Trading securities	$	17.9	$	11.3	$	6.6	$	–
Derivative assets	5.6		–		5.6		–
Bank drafts	24.8		24.8		–		–
Liabilities
Derivative liabilities	$	5.2	$	.7	$	4.5	$	–

Trading securities include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value.  As of October 1, 2016, trading securities of $.4 million and $18.5 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets. As of January 2, 2016, trading securities of $.3 million and $17.6 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets.  Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy.  Derivatives measured based on foreign exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than three months) are valued at face value due to their short-term nature and were included in “Other current assets” in the unaudited Condensed Consolidated Balance Sheets.

We utilized an income approach to estimate the fair values of the identifiable intangibles acquired from Mactac, using primarily Level 3 inputs. The discount rates we used to value these assets were between 10% and 12%.

15

Avery Dennison Corporation

Note 15.  Commitments and Contingencies

Legal Proceedings

We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business.  We have accrued liabilities for matters where it is probable that a loss will be incurred and the amount of loss can be reasonably estimated.  Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses.  If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly.  Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future.  The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.

Environmental

As of October 1, 2016, we have been designated by the U.S. Environmental Protection Agency (“EPA”) and/or other responsible state agencies as a potentially responsible party (“PRP”) at thirteen waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination.  No settlement of our liability related to any of the sites has been agreed upon.  We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.

We have accrued liabilities for sites where it is probable that a loss or cost will be incurred and the amount of loss or cost can be reasonably estimated.  These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors.  Because of the uncertainties associated with environmental assessment and remediation activities, future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses.  If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly.  In addition, we may be identified as a PRP at additional sites in the future.  The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.

The activity for the nine months ended October 1, 2016 related to our environmental liabilities was as follows:

(In millions)
Balance at January 2, 2016	$	17.7
Charges (reversals), net	6.1
Payments	(5.9		)
Balance at October 1, 2016	$	17.9

As of October 1, 2016 and January 2, 2016, approximately $9 million and $7 million, respectively, of the balance was classified as short-term and included in “Other current liabilities” in the unaudited Condensed Consolidated Balance Sheets.

16

Avery Dennison Corporation

Note 16.  Segment Information

Financial information from continuing operations by reportable segment is set forth below:

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Net sales to unaffiliated customers
Pressure-sensitive Materials	$	1,123.8		$	1,083.7		$	3,360.9		$	3,318.4
Retail Branding and Information Solutions	370.9			366.8			1,127.0			1,138.7
Vancive Medical Technologies	14.0			17.6			47.8			55.0
Net sales to unaffiliated customers	$	1,508.7		$	1,468.1		$	4,535.7		$	4,512.1
Intersegment sales
Pressure-sensitive Materials	$	16.3		$	14.6		$	49.0		$	46.5
Retail Branding and Information Solutions	.5			.3			1.6			1.5
Vancive Medical Technologies	.1			1.2			.4			4.4
Intersegment sales	$	16.9		$	16.1		$	51.0		$	52.4
Income from continuing operations before taxes
Pressure-sensitive Materials	$	138.7		$	130.5		$	425.6		$	383.2
Retail Branding and Information Solutions	28.4			25.1			82.8			54.3
Vancive Medical Technologies	(.9		)	(1.2		)	(.2		)	(4.7		)
Corporate expense	(23.5		)	(23.6		)	(112.0		)	(70.1		)
Interest expense	(14.7		)	(14.7		)	(45.4		)	(45.3		)
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Other expense, net by reportable segment
Pressure-sensitive Materials	$	2.7		$	1.1		$	11.2		$	13.8
Retail Branding and Information Solutions	1.5			3.9			7.3			29.4
Vancive Medical Technologies	.4			1.7			.5			3.4
Corporate	–			.3			41.4			2.4
Other expense, net	$	4.6		$	7.0		$	60.4		$	49.0
Other expense, net by type
Restructuring charges:
Severance and related costs	$	1.9		$	4.7		$	10.7		$	35.0
Asset impairment charges and lease cancellation costs	.7			1.9			3.9			5.5
Other items:
Loss from settlement of pension obligations	–			–			41.4			–
Transaction costs	2.0			–			4.1			–
Loss (gain) on sale of assets	–			–			.3			(1.7		)
Loss on sale of product line and related transaction and exit costs	–			.2			–			10.5
Legal settlements	–			.2			–			(.3		)
Other expense, net	$	4.6		$	7.0		$	60.4		$	49.0

Note 17.  Recent Accounting Requirements

In August 2016, the Financial Accounting Standards Board (“FASB”) issued guidance to reduce the diversity in the presentation of certain cash receipts and cash payments presented and classified in the statement of cash flows.  This guidance requires retrospective adoption and will be effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is permitted. We are currently assessing the impact of this guidance on our cash flows.

In March 2016, the FASB issued guidance to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance will be effective for fiscal years and interim periods beginning after December 15, 2016, and early adoption is permitted. Different components of the guidance require prospective, retrospective and/or modified retrospective adoption. We are currently assessing the timing of our adoption of this guidance and its impact on our financial position, results of operations, cash flows, and disclosures.

17

Avery Dennison Corporation

In March 2016, the FASB issued guidance on accounting for leases that requires lessees to recognize most leases on their balance sheets for the rights and obligations created by those leases. This guidance also requires enhanced disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases and will be effective for interim and annual periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective approach is required for adoption with respect to all leases that exist at or commence after the date of initial application with an option to use certain practical expedients. We are currently assessing the impact of this guidance on our financial position, results of operations, cash flows, and disclosures.

In July 2015, the FASB issued amended guidance to simplify the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value.  Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. This guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those fiscal years. We elected to early adopt this amended guidance in the first quarter of 2016 prospectively. The adoption of this guidance did not have an impact on our financial position, results of operations, cash flows, or disclosures.

In August 2014, the FASB issued a new standard that requires an entity to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern.  Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Under this new standard, substantial doubt exists when it is probable that the entity will be unable to meet its obligations as they become due within one year of the date the financial statements are issued.  If applicable, certain disclosures are required, including management’s plans to mitigate those relevant conditions or events to alleviate the substantial doubt.  This standard is effective for annual periods and interim periods within those annual periods ending after December 15, 2016.  Early adoption is permitted. We do not expect that adoption of this standard will have an impact on our financial position, results of operations, cash flows, or disclosures.

In May 2014, and in subsequent updates, the FASB issued revised guidance on revenue recognition. This revised guidance provides a single comprehensive model for accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This revised guidance will require an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This update creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which includes (i) identifying the contract(s) with the customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv) allocating the transaction price to the separate performance obligations, and (v) recognizing revenue when each performance obligation is satisfied. This revised guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This revised guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years, and can be applied retrospectively either to each prior reporting period presented or with the cumulative effect of adoption recognized at the date of initial application. Early adoption is permitted for fiscal periods beginning after December 15, 2016. We are currently evaluating which transition method to elect and we expect to adopt this guidance in the first quarter of 2018. Based on the information we have evaluated to date, we do not anticipate that the adoption of this revised guidance will have a significant impact on our financial position, results of operations, or cash flows.

18

Avery Dennison Corporation

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations, should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto, and includes the following sections:

Non-GAAP Financial Measures	19
Overview and Outlook	20
Analysis of Results of Operations for the Third Quarter	22
Results of Operations by Reportable Segment for the Third Quarter	23
Analysis of Results of Operations for the Nine Months Year-to-Date	25
Results of Operations by Reportable Segment for the Nine Months Year-to-Date	27
Financial Condition	29
Recent Accounting Requirements	32

NON-GAAP FINANCIAL MEASURES

We report financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessment of our performance and operating trends, as well as our liquidity.

Our non-GAAP financial measures exclude the impact of certain events, activities, and strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, both positive and negative, of certain items, we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

We use the following non-GAAP financial measures in this MD&A:

·Organic sales change refers to the increase or decrease in sales excluding the estimated impact of currency translation, product line exits, acquisitions and divestitures, and, where applicable, the extra week in our fiscal year. The estimated impact of currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. We believe that organic sales change assists investors in evaluating the sales growth from the ongoing activities of our businesses and provides improved comparability of our results from period to period.

·Free cash flow refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments, plus (minus) free cash outflow (inflow) from discontinued operations. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions.

·Operational working capital refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as current assets held for sale. We believe that operational working capital assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.

19

Avery Dennison Corporation

OVERVIEW AND OUTLOOK

Prior Period Financial Statement Revision

Certain prior period amounts have been revised to reflect the impact of certain adjustments. Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements for more information.

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Three Months Ended		Nine Months Ended
	October 1, 2016		October 1, 2016
Reported sales change	3	%	1	%
Foreign currency translation	2		3
Acquisitions/divestiture	(2	)	–
Organic sales change	3	%	4	%

In the three and nine months ended October 1, 2016, net sales increased on an organic basis primarily due to higher volume.

Income from Continuing Operations

Income from continuing operations increased approximately $41 million in the first nine months of 2016 compared to the same period last year. The primary factors affecting income from continuing operations for the first nine months of 2016 were as follows:

Positive factors:

·Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs

·Higher volume

·Lower restructuring charges

Offsetting factors:

·Higher employee-related costs

·Loss from settlement of pension obligations

·Net impact of pricing and raw material input costs

·Unfavorable mix

Cost Reduction Actions

2015/2016 Actions

During the first nine months ended October 1, 2016, we recorded $15 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015 that we expect to continue through 2016 (“2015/2016 Actions”). These charges consisted of severance and related costs for the reduction of approximately 310 positions, lease cancellation costs, and asset impairment charges.

During fiscal year 2015, we recorded $26.1 million in restructuring charges, net of reversals, related to our 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 430 positions, lease cancellation costs, and asset impairment charges.

No employees impacted by our 2015/2016 Actions taken through October 1, 2016 remained employed with us as of such date. We expect charges and payments related to these actions to be substantially completed in 2016.

2014/2015 Actions

During fiscal year 2015, we recorded $33.4 million in restructuring charges, net of reversals, related to restructuring actions we initiated in 2014 that continued through the second quarter of 2015 (“2014/2015 Actions”). These charges consisted of severance and related costs for the reduction of approximately 605 positions, lease cancellation costs, and asset impairment charges.

Approximately 25 employees impacted by our 2014/2015 Actions remained employed with us as of October 1, 2016. We expect charges and payments related to these actions to be substantially completed in 2016.

20

Avery Dennison Corporation

Impact of Cost Reduction Actions

In 2016, we expect to realize more than $75 million in savings, net of transition costs, from our 2015/2016 Actions and 2014/2015 Actions.  We anticipate carryover savings from these actions in 2017.

Restructuring charges were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.

Acquisitions

On August 1, 2016, we completed the acquisition of the European business of MACtac (“Mactac”) from Platinum Equity through the purchase of Evergreen Holding V, LLC. Mactac manufactures pressure-sensitive materials that complement our existing graphics portfolio and has been included in our Pressure-sensitive Materials segment. The total consideration for this acquisition, net of cash received, was approximately $222 million, which we funded primarily through existing credit facilities. The purchase price is subject to certain adjustments in accordance with the terms of the purchase agreement.

Due to the time required to complete our assessment, the final valuation of certain acquired assets and liabilities, including property, plant and equipment, intangible assets, taxes, and environmental and asset retirement obligations, is currently pending.

This acquisition was not material to our condensed consolidated financial statements.

Free Cash Flow

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net cash provided by operating activities	$	365.7		$	282.2
Purchases of property, plant and equipment	(104.9		)	(89.6		)
Purchases of software and other deferred charges	(16.6		)	(9.0		)
Proceeds from sales of property, plant and equipment	4.3			7.1
Purchases of investments, net	(.8		)	(.2		)
Plus: free cash outflow from discontinued operations	–			.6
Free cash flow	$	247.7		$	191.1

During the first nine months of 2016, cash flow from operating activities increased compared to the same period last year primarily due to higher net income, lower income tax payments, and benefits from changes in operational working capital, partially offset by higher incentive compensation payments. During the first nine months of 2016, free cash flow increased compared to the same period last year primarily due to higher cash flow from operating activities, partially offset by higher capital and software expenditures in 2016.

Outlook

Certain factors that we believe may contribute to our full year 2016 results are described below:

·We expect net sales growth of 1% to 1.5%, including organic sales growth of 3% to 3.5%, the impact of currency translation, and the effect of acquisitions net of divestitures.

·We expect earnings to increase.

·Based on currency rates in effect during October 2016, we expect currency translation to reduce net sales by approximately 2.5% and reduce pre-tax income by approximately $16 million.

·We expect the Mactac acquisition to increase our full-year reported net sales by approximately 1% and immaterially impact net income due to related transition costs.

·We expect our full-year effective tax rate to be approximately 33%.

·We anticipate capital and software expenditures of approximately $200 million.

·We estimate cash restructuring charges of approximately $20 million.

21

Avery Dennison Corporation

ANALYSIS OF RESULTS OF OPERATIONS FOR THE THIRD QUARTER

Income from Continuing Operations before Taxes

	Three Months Ended
(In millions, except percentages)	October 1, 2016			October 3, 2015
Net sales	$	1,508.7		$	1,468.1
Cost of products sold	1,091.1			1,062.2
Gross profit	417.6			405.9
Marketing, general and administrative expense	270.3			268.1
Interest expense	14.7			14.7
Other expense, net	4.6			7.0
Income from continuing operations before taxes	$	128.0		$	116.1
Gross profit margin	27.7		%	27.6		%

Gross Profit Margin

Gross profit margin for the third quarter of 2016 increased compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, and higher volume, partially offset by the net impact of pricing and raw material input costs, higher employee-related costs, and unfavorable mix.

Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the third quarter of 2016 compared to the same period last year reflecting higher employee-related costs and other items, partially offset by benefits from productivity initiatives, including savings from restructuring, net of transition costs.

Other Expense, net

	Three Months Ended
(In millions)	October 1, 2016		October 3, 2015
Other expense, net by type
Restructuring charges:
Severance and related costs	$	1.9	$	4.7
Asset impairment charges and lease cancellation costs	.7		1.9
Other items:
Transaction costs	2.0		–
Loss on sale of product line	–		.2
Legal settlement	–		.2
Other expense, net	$	4.6	$	7.0

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding charges associated with restructuring.

Net Income and Earnings per Share

	Three Months Ended
(In millions, except per share amounts)	October 1, 2016			October 3, 2015
Income from continuing operations before taxes	$	128.0		$	116.1
Provision for income taxes	38.9			34.8
Income from continuing operations	89.1			81.3
Loss from discontinued operations	–			.4
Net income	$	89.1		$	81.7
Net income per common share	$	1.00		$	.89
Net income per common share, assuming dilution	.98			.88
Effective tax rate for continuing operations	30.4		%	30.0		%

Provision for Income Taxes

The effective tax rate for the three months ended October 1, 2016 reflected the impact of favorable geographic mixture of pretax income and included the following: $4.8 million of tax expense resulting from return to provision adjustments pursuant to the completion of the 2015 U.S. federal tax return; $1 million of tax benefit from our change in judgment about

22

Avery Dennison Corporation

tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; $17.7 million of tax expense associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries; and $11.1 million of tax benefit resulting from effective settlements of tax examinations in various foreign jurisdictions.

The effective tax rate for continuing operations for the three months ended October 3, 2015 included $4.2 million of tax benefit resulting from return to provision adjustments pursuant to the completion of the 2014 U.S. federal tax return and $.9 million of tax benefit from a favorable foreign tax law change.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events, and the timing of repatriation of foreign earnings.  Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE THIRD QUARTER

Operating income refers to income before interest and taxes.

Pressure-sensitive Materials

	Three Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net sales including intersegment sales	$	1,140.1		$	1,098.3
Less intersegment sales	(16.3		)	(14.6		)
Net sales	$	1,123.8		$	1,083.7
Operating income(1)	138.7			130.5
(1)Included costs associated with restructuring in both years and transaction costs in 2016.	$	2.7		$	1.1

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Three Months Ended
	October 1, 2016
Reported sales change	4	%
Foreign currency translation	2
Acquisitions	(2	)
Organic sales change(1)	3	%

(1)Total may not sum due to rounding

In the third quarter of 2016, net sales increased on an organic basis primarily due to higher volume. Net sales increased on an organic basis at a high-single digit rate in emerging markets and at a low-single digit rate in Western Europe, and decreased on an organic basis at a low-single digit rate in North America.

In the third quarter of 2016, net sales increased on an organic basis at a mid-single digit rate for the Materials product group. In the third quarter of 2016, net sales decreased on an organic basis at a low-double digit rate for the Performance Tapes product group primarily due to a program loss with a large customer.

Operating Income

Operating income increased in the third quarter of 2016 compared to the same period last year due to benefits from productivity initiatives, including savings from restructuring, net of transition costs, and higher volume, partially offset by the net impact of pricing and raw material input costs and unfavorable mix.

23

Avery Dennison Corporation

Retail Branding and Information Solutions

	Three Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net sales including intersegment sales	$	371.4		$	367.1
Less intersegment sales	(.5		)	(.3		)
Net sales	$	370.9		$	366.8
Operating income(1)	28.4			25.1
(1)Included costs associated with restructuring in both years and loss on sale of a product line in 2015.	$	1.5		$	3.9

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Three Months Ended
	October 1, 2016
Reported sales change	1	%
Foreign currency translation	1
Organic sales change	2	%

In the third quarter of 2016, net sales increased on an organic basis due to higher volume from sales of radio-frequency identification products.

Operating Income

Operating income increased in the third quarter of 2016 compared to the same period last year primarily reflecting benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and higher volume, partially offset by higher employee-related costs and other items.

Vancive Medical Technologies

	Three Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net sales including intersegment sales	$	14.1		$	18.8
Less intersegment sales	(.1		)	(1.2		)
Net sales	$	14.0		$	17.6
Operating loss(1)	(.9		)	(1.2		)
(1)Included costs associated with restructuring in both years.	$	.4		$	1.7

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Three Months Ended
	October 1, 2016
Reported sales change	(20	) %
Foreign currency translation	–
Organic sales change	(20	) %

In the third quarter of 2016, net sales decreased on an organic basis due to lower volume.

Operating Loss

Operating loss decreased in the third quarter of 2016 compared to the same period last year primarily due to lower restructuring charges and a reduction in operating costs, partially offset by lower volume.

24

Avery Dennison Corporation

ANALYSIS OF RESULTS OF OPERATIONS FOR THE NINE MONTHS YEAR-TO-DATE

Income from Continuing Operations before Taxes

	Nine Months Ended
(In millions, except percentages)	October 1, 2016			October 3, 2015
Net sales	$	4,535.7		$	4,512.1
Cost of products sold	3,261.4			3,258.6
Gross profit	1,274.3			1,253.5
Marketing, general and administrative expense	817.7			841.8
Interest expense	45.4			45.3
Other expense, net	60.4			49.0
Income from continuing operations before taxes	$	350.8		$	317.4
Gross profit margin	28.1		%	27.8		%

Gross Profit Margin

Gross profit margin for the first nine months of 2016 increased compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, higher volume, and the impact of changes in currency rates, partially offset by higher employee-related costs, unfavorable mix, and the net impact of pricing and raw material input costs.

Marketing, General and Administrative Expense

Marketing, general and administrative expense decreased in the first nine months of 2016 compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, lower restructuring charges, and the favorable impact of foreign currency translation, partially offset by higher employee-related costs.

Other Expense, net

	Nine Months Ended
(In millions)	October 1, 2016		October 3, 2015
Other expense, net by type
Restructuring charges:
Severance and related costs	$	10.7	$	35.0
Asset impairment charges and lease cancellation costs	3.9		5.5
Other items:
Loss from settlement of pension obligations	41.4		–
Transaction costs	4.1		–
Loss (gain) on sale of assets	.3		(1.7		)
Loss on sale of product line and related transaction and exit costs	–		10.5
Legal settlement	–		(.3		)
Other expense, net	$	60.4	$	49.0

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding costs associated with restructuring.

Refer to Note 6, “Pension and Other Postretirement Benefits,” to the unaudited Condensed Consolidated Financial Statements for more information regarding loss from settlement of pension obligations.

25

Avery Dennison Corporation

Net Income and Earnings per Share

	Nine Months Ended
(In millions, except per share amounts)	October 1, 2016			October 3, 2015
Income from continuing operations before taxes	$	350.8		$	317.4
Provision for income taxes	92.1			99.5
Income from continuing operations	258.7			217.9
Loss from discontinued operations	–			(.6		)
Net income	$	258.7		$	217.3
Net income per common share	$	2.90		$	2.39
Net income per common share, assuming dilution	2.85			2.34
Effective tax rate for continuing operations	26.3		%	31.3		%

Provision for Income Taxes

The effective tax rate for the nine months ended October 1, 2016 reflected the impact of favorable geographic mixture of pretax income and included the following: $3.1 million of tax expense resulting from return to provision adjustments pursuant to the completion of the 2015 U.S. federal tax return; $7.1 million of tax benefit from our change in judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; $26.9 million of tax expense associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries; $11.1 million of tax benefit resulting from effective settlements of tax examinations in various foreign jurisdictions; $6.7 million of tax benefit from the release of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority; and $3.3 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years.

The effective tax rate for the nine months ended October 1, 2016 compared to the effective tax rate for the nine months ended October 3, 2015 was impacted by favorable effective settlements in various foreign jurisdictions, favorable geographic mixture of pretax income, and a tax benefit from the release of valuation allowances against deferred tax assets.

The effective tax rate for continuing operations for the nine months ended October 3, 2015 included $4.2 million of tax benefit resulting from return to provision adjustments pursuant to the completion of the 2014 U.S. federal tax return; $.9 million of tax benefit from a favorable foreign tax law change; $5.4 million of tax expense associated with the tax cost to repatriate non-permanently reinvested 2015 earnings of certain foreign subsidiaries; $1.6 million of net tax benefit related to changes in the effective tax rates in certain foreign municipalities; and $4.2 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events and the timing of repatriation of foreign earnings.  Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

26

Avery Dennison Corporation

RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE NINE MONTHS YEAR-TO-DATE

Operating income refers to income from continuing operations before interest and taxes.

Pressure-sensitive Materials

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net sales including intersegment sales	$	3,409.9		$	3,364.9
Less intersegment sales	(49.0		)	(46.5		)
Net sales	$	3,360.9		$	3,318.4
Operating income(1)	425.6			383.2
(1)Included costs associated with restructuring in both years, transaction costs in 2016, and a gain on sale of an asset in 2015.	$	11.2		$	13.8

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Nine Months Ended
	October 1, 2016
Reported sales change	1	%
Foreign currency translation	4
Acquisitions	(1	)
Organic sales change	4	%

In the first nine months of 2016, net sales increased on an organic basis primarily due to higher volume. Net sales increased on an organic basis at a high-single digit rate in emerging markets and at a low-single digit rate in Western Europe, and decreased on an organic basis at a low-single digit rate in North America.

In the first nine months of 2016, net sales increased on an organic basis at a mid-single digit rate for the Materials product group. In the first nine months of 2016, net sales decreased on an organic basis at a high-single digit rate for the Performance Tapes product group primarily due to a program loss with a large customer.

Operating Income

Operating income increased in the first nine months of 2016 compared to the same period last year primarily reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, and higher volume, partially offset by higher employee-related costs, unfavorable mix, and the unfavorable impact of currency translation.

Retail Branding and Information Solutions

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net sales including intersegment sales	$	1,128.6		$	1,140.2
Less intersegment sales	(1.6		)	(1.5		)
Net sales	$	1,127.0		$	1,138.7
Operating income(1)	82.8			54.3
(1)Included costs associated with restructuring in both years, transaction costs in 2016, loss on sale of an asset in 2016, loss on sale of a product line in 2015, and a legal settlement in 2015.	$	7.3		$	29.4

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Nine Months Ended
	October 1, 2016
Reported sales change	(1	) %
Foreign currency translation	2
Product line divestiture	2
Organic sales change	3	%

In the first nine months of 2016, net sales increased on an organic basis due to higher volume from sales of radio-frequency identification products.

Operating Income

Operating income increased in the first nine months of 2016 compared to the same period last year primarily reflecting benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, higher volume, lower restructuring charges, and the loss on sale of a product line and related costs in the prior year, partially offset by higher employee-related costs and the impact of strategic pricing actions.

27

Avery Dennison Corporation

Vancive Medical Technologies

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net sales including intersegment sales	$	48.2		$	59.4
Less intersegment sales	(.4		)	(4.4		)
Net sales	$	47.8		$	55.0
Operating loss(1)	(.2		)	(4.7		)
(1)Included costs associated with restructuring in both years.	$	.5		$	3.4

Net Sales

The factors impacting the reported sales change are shown in the table below:

	Nine Months Ended
	October 1, 2016
Reported sales change	(13	) %
Foreign currency translation	–
Organic sales change	(13	) %

In the first nine months of 2016, net sales decreased on an organic basis primarily due to lower volume.

Operating Loss

Operating loss decreased in the first nine months of 2016 compared to the same period last year reflecting lower operating costs and lower restructuring charges, partially offset by lower volume.

28

Avery Dennison Corporation

FINANCIAL CONDITION

Liquidity

Operating Activities

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net income	$	258.7		$	217.3
Depreciation and amortization	135.5			142.8
Provision for doubtful accounts and sales returns	33.8			36.6
Net losses from asset impairments and sales/disposals of assets	3.8			10.9
Stock-based compensation	20.1			18.4
Loss from settlement of pension obligations	41.4			–
Other non-cash expense and loss	34.7			38.9
Changes in assets and liabilities and other adjustments	(162.3		)	(182.7		)
Net cash provided by operating activities	$	365.7		$	282.2

For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in “Analysis of Selected Balance Sheet Accounts”).

During the first nine months of 2016, cash flow from operating activities increased compared to the same period last year primarily due to higher net income, lower income tax payments, and benefits from changes in operational working capital, partially offset by higher incentive compensation payments.

Investing Activities

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Purchases of property, plant and equipment	$	(104.9	)	$	(89.6	)
Purchases of software and other deferred charges	(16.6		)	(9.0		)
Proceeds from sales of property, plant and equipment	4.3			7.1
Purchases of investments, net	(.8		)	(.2		)
Payments for acquisitions, net of cash acquired	(227.5		)	–
Other	–			1.5
Net cash used in investing activities	$	(345.5	)	$	(90.2	)

Capital and Software Spending

During the first nine months of 2016 and 2015, we invested in new equipment to support growth, primarily in Asia, and to improve manufacturing productivity.

During the first nine months of 2016, information technology investments were primarily associated with standardization initiatives in North America. During the first nine months of 2015, information technology investments were primarily associated with standardization initiatives in Asia and North America.

Payments for Acquisitions, Net of Cash Acquired

In connection with the Mactac acquisition, we paid consideration, net of cash received, of approximately $222 million, which we funded primarily through existing credit facilities. The purchase price is subject to certain adjustments in accordance with the terms of the purchase agreement.

Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

Other

In May 2015, we received $1.5 million from the sale of a product line in our RBIS reportable segment.  Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements for more information.

29

Avery Dennison Corporation

Financing Activities

	Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015
Net increase (decrease) in borrowings (maturities of three months or less)	$	242.0		$	(109.8	)
Payments of debt (maturities greater than three months)	(1.9		)	(6.2		)
Dividends paid	(106.2		)	(99.6		)
Share repurchases	(181.5		)	(108.5		)
Proceeds from exercises of stock options, net	63.4			78.4
Other	(4.4		)	(1.2		)
Net cash provided by (used in) financing activities	$	11.4		$	(246.9	)

Borrowings and Repayment of Debt

During the first nine months of 2016, our commercial paper borrowings were used mainly to fund the Mactac acquisition, share repurchase activity, capital expenditures, and dividend payments. During the first nine months of 2015, our commercial paper borrowings were used mainly to fund share repurchase activity, dividend payments, and capital expenditures given the seasonality of our cash flow.

Dividend Payments

We paid dividends of $1.19 per share in the first nine months of 2016 compared to $1.09 per share in the same period last year. In April 2016, we increased our quarterly dividend to $.41 per share, representing an 11% increase from our previous dividend rate of $.37 per share.

Share Repurchases

During the first nine months of 2016, we repurchased approximately 2.7 million shares of our common stock at an aggregate cost of $181.5 million. During the first nine months of 2015, we repurchased approximately 1.9 million shares of our common stock at an aggregate cost of $108.5 million.

As of October 1, 2016, approximately $186 million remained authorized for repurchase under our current board authorization of $500 million (exclusive of any fees, commissions, or other expenses related to such repurchases).

Analysis of Selected Balance Sheet Accounts

Long-lived Assets

In the nine months ended October 1, 2016, goodwill increased by approximately $135 million to $822 million, which primarily reflected the preliminary valuation of goodwill associated with the Mactac acquisition and foreign currency translation.

In the nine months ended October 1, 2016, other intangibles resulting from business acquisitions, net, increased by approximately $25 million to $71 million, which reflected preliminary valuation of other intangibles resulting from the Mactac acquisition, partially offset by current year amortization expense.

Refer to Note 4, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

In the nine months ended October 1, 2016, other assets decreased by approximately $8 million to $398 million, which reflected amortization expense related to software and other deferred charges, net of purchases, partially offset by an increase in the cash surrender value of our corporate-owned life insurance policies.

Shareholders’ Equity Accounts

In the nine months ended October 1, 2016, the balance of our shareholders’ equity increased by approximately $77 million to $1.04 billion, which primarily reflected net income, the use of treasury shares to settle exercises of stock options and vesting of stock-based awards and to fund contributions to our U.S. defined contribution plan, partially offset by share repurchases and dividend payments.

Impact of Foreign Currency Translation

	Nine Months Ended
(In millions)	October 1, 2016
Change in net sales	$	(131	)
Change in net income	(10		)

30

Avery Dennison Corporation

International operations generated approximately 74% of our net sales during the nine months ended October 1, 2016.  Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first nine months of 2016 compared to the same period last year primarily related to sales in China, Argentina, and Brazil, as well as euro-denominated sales.

Effect of Foreign Currency Transactions

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold.  In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate.

Analysis of Selected Financial Ratios

We utilize the financial ratios discussed below to assess our financial condition and operating performance.

Working Capital and Operational Working Capital Ratios

Working capital (current assets minus current liabilities), as a percentage of annualized net sales, improved in the first nine months of 2016 compared to the same period last year primarily driven by increases in short-term debt associated with the reclassification of senior notes to current portion of long-term debt due on October 1, 2017, and increases in commercial paper borrowings to fund the Mactac acquisition.  The improvement in the working capital ratio was also attributable to a decrease in current deferred taxes as a result of the prospective adoption of accounting guidance to classify deferred taxes as non-current in the fourth quarter of 2015, partially offset by an increase in trade accounts receivable.

Operational working capital, as a percentage of annualized net sales, is reconciled with working capital below.  Our objective is to minimize our investment in operational working capital, as a percentage of annualized net sales, to maximize our cash flow and return on investment.

	Nine Months Ended
(Dollars in millions)	October 1, 2016			October 3, 2015
(A) Working capital	$	(42.5	)	$	451.3
Reconciling items:
Cash and cash equivalents	(189.4		)	(143.8		)
Other current assets	(183.3		)	(260.8		)
Assets held for sale	(5.9		)	–
Short-term borrowings and current portion of long-term debt and capital leases	587.6			85.1
Other current liabilities	601.8			539.2
(B) Operational working capital	$	768.3		$	671.0
(C) Annualized net sales (year-to-date sales, divided by three and multiplied by four)	$	6,047.6		$	6,016.1
Working capital, as a percentage of annualized net sales (A) ÷ (C)	(.7		)%	7.5		%
Operational working capital, as a percentage of annualized net sales (B) ÷ (C)	12.7		%	11.2		%

Accounts Receivable Ratio

The average number of days sales outstanding was 63 in the first nine months of 2016 compared to 61 in the first nine months of 2015. The average number of days outstanding was calculated using the three-quarter average trade accounts receivable balance divided by the average daily sales for the first nine months of 2016 and 2015, respectively.  The increase in the average number of days sales outstanding from the prior year primarily reflected the timing of collections and the impact of foreign currency translation.

Inventory Ratio

Average inventory turnover decreased from 8.5 in the first nine months of 2015 to 8.1 in the first nine months of 2016. The average inventory turnover was calculated using the annualized cost of sales (cost of sales for the first nine months of 2016 and 2015, respectively, divided by three and multiplied by four) divided by the three-quarter average inventory balance.  The decrease in the current year average inventory turnover primarily reflected the timing of inventory purchases.

Accounts Payable Ratio

The average number of days payables outstanding was 72 in the first nine months of 2016 compared to 71 in the first nine months of 2015. The average number of days payable outstanding was calculated using the three-quarter average accounts payable balance divided

31

Avery Dennison Corporation

by the average daily cost of products sold for the first nine months of 2016 and 2015, respectively. The increase in average number of days payable outstanding from the prior year primarily reflected the impact of foreign currency translation.

Capital Resources

Capital resources include cash flows from operations, cash and cash equivalents and debt financing.  At October 1, 2016, we had cash and cash equivalents of $189.4 million held in accounts at third-party financial institutions.

Our cash balances are held in numerous locations throughout the world.  At October 1, 2016, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

To meet U.S. cash requirements, we have several cost-effective liquidity options available.  These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings. However, if we were to repatriate incremental foreign earnings, we may be subject to additional taxes in the U.S.

The Revolver is used as a back-up facility for our commercial paper program and can be used to finance other corporate requirements. The Revolver is scheduled to mature on October 3, 2019, but the maturity date may be extended for additional one-year periods under certain circumstances. The commitments under the Revolver may be increased by up to $325 million, subject to lender approval and other customary requirements.  As of October 1, 2016, there was no balance outstanding under the Revolver. Refer to Note 5, “Debt and Capital Leases,” to the unaudited Condensed Consolidated Financial Statements for more information.

In March 2016, we entered into an agreement with three commercial paper dealers to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Proceeds from issuances under this program may be used for general corporate purposes. The maturities of the notes may vary, but may not exceed 364 days from the date of issuance. Our payment obligations with respect to any notes issued under this program would be backed by the Revolver. There are no financial covenants under this program. As of October 1, 2016, $210.3 million was outstanding under this program.

We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.

Capital from Debt

Our total debt increased by approximately $243 million in the first nine months of 2016 to $1.28 billion, primarily reflecting an increase in commercial paper borrowings used to fund the Mactac acquisition, share repurchase activity, dividend payments, and capital expenditures, as well as an increase in short-term borrowings to support operational requirements.

Credit ratings are a significant factor in our ability to raise short- and long-term financing.  The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings.  A downgrade of our short-term credit ratings below current levels could impact our ability to access commercial paper markets.  If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team.  We remain committed to maintaining an investment grade rating.

We will explore a debt offering in the first half of 2017 to refinance the senior notes that will mature in 2017, as well as the commercial paper used to fund the Mactac acquisition.

Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters

Refer to Note 15, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements.

RECENT ACCOUNTING REQUIREMENTS

Refer to Note 17, “Recent Accounting Requirements,” to the unaudited Condensed Consolidated Financial Statements.

32

Avery Dennison Corporation

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the 2015 fiscal year ended January 2, 2016.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California.  As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report.  Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

Changes in Internal Control Over Financial Reporting

We periodically assess our internal control environment. During 2014, we began a phased implementation of a new transactional system in our RBIS reportable segment that is expected to continue through 2018. Processes affected by this implementation include, among other things, order management, pricing, shipping, general accounting and planning. Where appropriate, we are reviewing related internal controls and making changes. Other than this implementation, there have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We acquired Mactac on August 1, 2016, and we are currently in the process of reviewing our internal control structure. We will make any necessary changes as we integrate Mactac into our overall internal control over financial reporting process.

33

Avery Dennison Corporation

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Refer to “Legal Proceedings” in Note 15, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements in Part 1, Item 1.

ITEM 1A.  RISK FACTORS

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended January 2, 2016.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a)Not Applicable

(b)Not Applicable

(c)Repurchases of Equity Securities by Issuer

Repurchases by us or our “affiliated purchasers” (as defined in Rule 10b-18(a)(3) of the Exchange Act) of registered equity securities in the three fiscal months of the third quarter of 2016 are listed in the following table.

Period(1)	Total number of shares purchased(2)	Average price paid per share		Total number of shares purchased as part of publicly announced plans(2)(3)	Approximate dollar value of shares that may yet be purchased under the plans(4)
July 3, 2016 – July 30, 2016	106.5	$	73.01	106.5
July 31, 2016 – August 27, 2016	10.0	78.03		10.0
August 28, 2016 – October 1, 2016	166.7	77.14		166.7
Total	283.2	$	75.62	283.2	$	185.7

(1) The periods shown are our fiscal months during the thirteen-week quarter ended October 1, 2016.

(2) Shares in thousands.

(3) On December 4, 2014, our Board of Directors authorized the repurchase of shares of our common stock in the aggregate amount of up to $500 million (exclusive of any fees, commissions or other expenses related to such purchases), in addition to any outstanding shares authorized under any previous Board authorization.  This is the only authorization currently in effect and it will remain in effect until the shares authorized thereby have been repurchased.

(4) Dollars in millions.

Repurchased shares may be reissued under our stock option and incentive plan or used for other corporate purposes.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not Applicable

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable

34

Avery Dennison Corporation

ITEM 5. OTHER INFORMATION

Not Applicable

ITEM 6. EXHIBITS

Exhibit 12*	Computation of Ratio of Earnings to Fixed Charges
Exhibit 31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1**	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 32.2**	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101.INS	XBRL Instance Document
Exhibit 101.SCH	XBRL Extension Schema Document
Exhibit 101.CAL	XBRL Extension Calculation Linkbase Document
Exhibit 101.LAB	XBRL Extension Label Linkbase Document
Exhibit 101.PRE	XBRL Extension Presentation Linkbase Document
Exhibit 101.DEF	XBRL Extension Definition Linkbase Document

*Filed herewith.

**Furnished herewith.

35

Avery Dennison Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AVERY DENNISON CORPORATION

(Registrant)

/s/ Anne L. Bramman

Anne L. Bramman

Senior Vice President and Chief Financial Officer

(Principal Financial Officer)

/s/ Lori J. Bondar

Lori J. Bondar

Vice President, Controller, and Chief Accounting Officer

(Principal Accounting Officer)

November 1, 2016

36

EX-12

Exhibit 12

Avery Dennison Corporation

AVERY DENNISON CORPORATION AND SUBSIDIARIES

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

	Three Months Ended						Nine Months Ended
(Dollars in millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Earnings:
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Add: Fixed charges(1)	20.5			21.4			62.7			65.4
Amortization of capitalized interest	1.0			1.2			3.2			3.5
Less: Capitalized interest	(.8		)	(.9		)	(2.1		)	(2.5		)
	$	148.7		$	137.8		$	414.6		$	383.8
Fixed charges:(1)
Interest expense	$	14.7		$	14.7		$	45.4		$	45.3
Capitalized interest	.8			.9			2.1			2.5
Interest portion of leases	5.0			5.8			15.2			17.6
	$	20.5		$	21.4		$	62.7		$	65.4
Ratio of Earnings to Fixed Charges	7.3			6.4			6.6			5.9

(1) The ratios of earnings to fixed charges were computed by dividing earnings by fixed charges.  For this purpose, “earnings” consist of income from continuing operations before taxes plus fixed charges and amortization of capitalized interest, less capitalized interest.  “Fixed charges” consist of interest expense, capitalized interest and the portion of rent expense (estimated to be 35%) on operating leases deemed representative of interest.

EX-31.1

Exhibit 31.1

Avery Dennison Corporation

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Mitchell R. Butier, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Avery Dennison Corporation;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Mitchell R. Butier

Mitchell R. Butier

President and Chief Executive Officer

November 1, 2016

EX-31.2

Exhibit 31.2

Avery Dennison Corporation

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Anne L. Bramman, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Avery Dennison Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Anne L. Bramman

Anne L. Bramman

Senior Vice President and Chief Financial Officer

November 1, 2016

EX-32.1

Exhibit 32.1

Avery Dennison Corporation

CERTIFICATION OF CHIEF EXECUTIVE OFFICER*

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:

(i)       the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended October 1, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)      the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 1, 2016

/s/ Mitchell R. Butier

Mitchell R. Butier

President and Chief Executive Officer

* The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.

EX-32.2

Exhibit 32.2

Avery Dennison Corporation

CERTIFICATION OF CHIEF FINANCIAL OFFICER*

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of her knowledge, that:

(i)       the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended October 1, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)      the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 1, 2016

/s/ Anne L. Bramman

Anne L. Bramman

Senior Vice President and Chief Financial Officer

* The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.

XML

Document and Entity Information - shares	9 Months Ended
	Oct. 01, 2016	Oct. 29, 2016
Document and Entity Information
Entity Registrant Name	Avery Dennison Corp
Entity Central Index Key	0000008818
Document Type	10-Q
Document Period End Date	Oct. 01, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		88,991,587
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Oct. 01, 2016	Jan. 02, 2016
Current assets:
Cash and cash equivalents	$ 189.4	$ 158.8
Trade accounts receivable, less allowances of $40.6 and $31.5 at October 1, 2016 and January 2, 2016, respectively	1,069.7	964.7
Inventories, net	565.3	478.7
Assets held for sale	5.9	2.5
Other current assets	183.3	170.7
Total current assets	2,013.6	1,775.4
Property, plant and equipment	2,685.5	2,599.9
Accumulated depreciation	(1,780.1)	(1,752.0)
Property, plant and equipment, net	905.4	847.9
Goodwill	821.6	686.2
Other intangibles resulting from business acquisitions, net	70.9	45.8
Non-current deferred income taxes	390.7	372.2
Other assets	398.2	406.2
Total assets	4,600.4	4,133.7
Current liabilities:
Short-term borrowings and current portion of long-term debt and capital leases	587.6	95.3
Accounts payable	866.7	814.6
Accrued payroll and employee benefits	207.8	194.6
Other current liabilities	394.0	354.6
Total current liabilities	2,056.1	1,459.1
Long-term debt and capital leases	713.0	963.6
Long-term retirement benefits and other liabilities	684.5	637.4
Non-current deferred and payable income taxes	104.4	107.9
Commitments and contingencies (see Note 15)
Shareholders' equity:
Common stock, $1 par value per share, authorized - 400,000,000 shares at October 1, 2016 and January 2, 2016; issued - 124,126,624 shares at October 1, 2016 and January 2, 2016; outstanding - 89,194,833 shares and 89,967,697 shares at October 1, 2016 and January 2, 2016, respectively	124.1	124.1
Capital in excess of par value	843.1	834.0
Retained earnings	2,444.1	2,277.6
Treasury stock at cost, 34,931,791 shares and 34,158,927 shares at October 1, 2016 and January 2, 2016, respectively	(1,699.9)	(1,587.0)
Accumulated other comprehensive loss	(669.0)	(683.0)
Total shareholders' equity	1,042.4	965.7
Total liabilities and shareholders' equity	$ 4,600.4	$ 4,133.7

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Oct. 01, 2016	Jan. 02, 2016
CONDENSED CONSOLIDATED BALANCE SHEETS
Trade accounts receivable, allowances (in dollars)	$ 40.6	$ 31.5
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, authorized shares	400,000,000	400,000,000
Common stock, issued shares	124,126,624	124,126,624
Common stock, outstanding shares	89,194,833	89,967,697
Treasury stock, shares	34,931,791	34,158,927

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 1,508.7	$ 1,468.1	$ 4,535.7	$ 4,512.1
Cost of products sold	1,091.1	1,062.2	3,261.4	3,258.6
Gross profit	417.6	405.9	1,274.3	1,253.5
Marketing, general and administrative expense	270.3	268.1	817.7	841.8
Interest expense	14.7	14.7	45.4	45.3
Other expense, net	4.6	7.0	60.4	49.0
Income from continuing operations before taxes	128.0	116.1	350.8	317.4
Provision for income taxes	38.9	34.8	92.1	99.5
Income from continuing operations	89.1	81.3	258.7	217.9
Income (loss) from discontinued operations		0.4		(0.6)
Net income	$ 89.1	$ 81.7	$ 258.7	$ 217.3
Net income per common share:
Continuing operations (in dollars per share)	$ 1.00	$ 0.89	$ 2.90	$ 2.39
Net income per common share (in dollars per share)	1.00	0.89	2.90	2.39
Net income (loss) per common share, assuming dilution:
Continuing operations (in dollars per share)	0.98	0.87	2.85	2.35
Discontinued operations (in dollars per share)		0.01		(0.01)
Net income per common share, assuming dilution (in dollars per share)	0.98	0.88	2.85	2.34
Dividends per common share (in dollars per share)	$ 0.41	$ 0.37	$ 1.19	$ 1.09
Weighted average number of shares outstanding:
Common shares (in shares)	89.1	91.5	89.2	91.1
Common shares, assuming dilution (in shares)	90.6	93.2	90.9	92.9

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net income	$ 89.1	$ 81.7	$ 258.7	$ 217.3
Other comprehensive income (loss), net of tax:
Foreign currency translation	15.5	(60.5)	21.1	(129.6)
Pension and other postretirement benefits	4.4	5.1	(6.9)	17.7
Cash flow hedges	(0.1)	(0.2)	(0.2)	(0.8)
Other comprehensive income (loss), net of tax	19.8	(55.6)	14.0	(112.7)
Total comprehensive income, net of tax	$ 108.9	$ 26.1	$ 272.7	$ 104.6

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015
Operating Activities
Net income	$ 258.7	$ 217.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	88.8	95.3
Amortization	46.7	47.5
Provision for doubtful accounts and sales returns	33.8	36.6
Net losses from asset impairments and sales/disposals of assets	3.8	10.9
Stock-based compensation	20.1	18.4
Loss from settlement of pension obligations	41.4
Other non-cash expense and loss	34.7	38.9
Changes in assets and liabilities and other adjustments	(162.3)	(182.7)
Net cash provided by operating activities	365.7	282.2
Investing Activities
Purchases of property, plant and equipment	(104.9)	(89.6)
Purchases of software and other deferred charges	(16.6)	(9.0)
Proceeds from sales of property, plant and equipment	4.3	7.1
Purchases of investments, net	(0.8)	(0.2)
Payments for acquisitions, net of cash acquired	(227.5)
Other		1.5
Net cash used in by investing activities	(345.5)	(90.2)
Financing Activities
Net increase (decrease) in borrowings (maturities of three months or less)	242.0	(109.8)
Payments of debt (maturities greater than three months)	(1.9)	(6.2)
Dividends paid	(106.2)	(99.6)
Share repurchases	(181.5)	(108.5)
Proceeds from exercises of stock options, net	63.4	78.4
Other	(4.4)	(1.2)
Net cash provided by (used in) financing activities	11.4	(246.9)
Effect of foreign currency translation on cash balances	(1.0)	(8.5)
Increase (decrease) in cash and cash equivalents	30.6	(63.4)
Cash and cash equivalents, beginning of year	158.8	207.2
Cash and cash equivalents, end of period	$ 189.4	$ 143.8

XML

General

9 Months Ended

Oct. 01, 2016

General

General

Note 1.  General

The unaudited Condensed Consolidated Financial Statements and notes in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and notes thereto in our 2015 Annual Report on Form 10-K, which should be read in conjunction with this Quarterly Report on Form 10-Q. The accompanying unaudited Condensed Consolidated Financial Statements include normal recurring adjustments necessary for a fair statement of our interim results.  Interim results of operations are not necessarily indicative of future results.

Fiscal Periods

The third quarters of 2016 and 2015 consisted of thirteen-week periods ending October 1, 2016 and October 3, 2015, respectively. The nine months ended October 1, 2016 and October 3, 2015 each consisted of thirty-nine-week periods.

Prior Period Financial Statement Revision

In the fourth quarter of 2015, we identified certain liquid short-term bank drafts with maturities greater than three months that were improperly classified as cash and cash equivalents instead of other current assets, which resulted in an overstatement of operating cash flows, and tax effects related to certain foreign pension plans that were not properly accounted for in our consolidated financial statements. We assessed the materiality of these errors on our financial statements for prior periods in accordance with United States Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 99, Materiality, codified in Accounting Standards Codification (“ASC”) 250, Presentation of Financial Statements, and concluded that they were not material to any prior annual or interim periods.  Consequently, in accordance with ASC 250 (SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements), we corrected these errors for all prior periods presented by revising the unaudited Condensed Consolidated Financial Statements and other financial information included herein.

The effects of the revision on our unaudited Condensed Consolidated Statements of Cash Flows were as follows:

	Nine Months Ended October 3, 2015
(In millions)	As Previously Reported			Adjustment			As Revised
Net cash provided by operating activities	$	290.3		$	(8.1	)	$	282.2
Decrease in cash and cash equivalents	(55.3		)	(8.1		)	(63.4		)
Cash and cash equivalents, beginning of year	227.0			(19.8		)	207.2
Cash and cash equivalents, end of period	171.7			(27.9		)	143.8

Sale of Product Line

In May 2015, we sold certain assets and transferred certain liabilities associated with a product line in our Retail Branding and Information Solutions (“RBIS”) reportable segment for $1.5 million.  The pre-tax loss from the sale, when combined with exit costs related to the sale, totaled $8.5 million. In the first quarter of 2015, we recorded an impairment charge of approximately $2 million related to certain long-lived assets of this product line, as well as $.6 million of other costs related to this sale. This loss and these costs were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

Discontinued Operations

Income (loss) from discontinued operations during the third quarter and nine months ended October 3, 2015 included tax benefits (expense) related to the completion of certain tax return filings related to the sale of our former Office and Consumer Products (“OCP”) and Designed and Engineered Solutions (“DES”) businesses. We continue to be subject to certain indemnification obligations under the terms of the purchase agreement. In addition, the tax liability associated with the sale remains subject to the completion of tax return filings in certain foreign jurisdictions where we formerly operated the OCP and DES businesses.

XML

Acquisitions

9 Months Ended

Oct. 01, 2016

Acquisitions

Acquisitions

Note 2. Acquisitions

On August 1, 2016, we completed the acquisition of the European business of MACtac (“Mactac”) from Platinum Equity through the purchase of Evergreen Holding V, LLC. Mactac manufactures pressure-sensitive materials that complement our existing graphics portfolio and has been included in our Pressure-sensitive Materials segment. The total consideration for this acquisition, net of cash received, was approximately $222 million, which we funded primarily through existing credit facilities. The purchase price is subject to certain adjustments in accordance with the terms of the purchase agreement

Due to the time required to complete our assessment, the final valuation of certain acquired assets and liabilities, including property, plant and equipment, intangible assets, taxes, and environmental and asset retirement obligations, is currently pending.

This acquisition was not material to our condensed consolidated financial statements.

XML

Inventories

9 Months Ended

Oct. 01, 2016

Inventories

Inventories

Note 3.  Inventories

Net inventories consisted of:

(In millions)	October 1, 2016		January 2, 2016
Raw materials	$	207.8	$	180.5
Work-in-progress	172.1		143.0
Finished goods	185.4		155.2
Inventories, net	$	565.3	$	478.7

XML

Goodwill and Other Intangibles Resulting from Business Acquisitions

9 Months Ended

Oct. 01, 2016

Goodwill and Other Intangibles Resulting from Business Acquisitions

Goodwill and Other Intangibles Resulting from Business Acquisitions

Note 4.  Goodwill and Other Intangibles Resulting from Business Acquisitions

Goodwill

Changes in the net carrying amount of goodwill for the nine months ended October 1, 2016, by reportable segment, were as follows:

(In millions)	Pressure-sensitive Materials		Retail Branding and Information Solutions		Total
Goodwill as of January 2, 2016	$	277.9	$	408.3	$	686.2
Acquired during current period(1)	125.0		–		125.0
Translation adjustments	7.2		3.2		10.4
Goodwill as of October 1, 2016	$	410.1	$	411.5	$	821.6

(1)  Goodwill acquired during the current period primarily related to the Mactac acquisition.

The carrying amounts of goodwill at October 1, 2016 and January 2, 2016 were net of accumulated impairment losses of $820 million, which were included in our RBIS reportable segment.

There was no goodwill associated with our Vancive Medical Technologies reportable segment.

In connection with the Mactac acquisition, we recognized an estimated $120 million of preliminary goodwill based on our expectation of synergies and other benefits of combining our businesses. These synergies and benefits include use of our existing commercial infrastructure to expand sales of products of the acquired business in a cost-efficient manner. The amount of goodwill recognized is not expected to be deductible for tax purposes.

Other Intangibles Resulting from Business Acquisitions

In connection with the Mactac acquisition, we acquired approximately $39 million of identifiable intangible assets, which includes finite-lived and indefinite-lived intangible assets. Identifiable intangible assets consist of customer relationships, trade names and trademarks, and patents and other acquired technology.  The table below summarizes the preliminary amounts and weighted average useful lives, if applicable, of these intangible assets:

	Amount (in millions)		Weighted-average amortization period (in years)
Customer relationships	$	22.8		15
Patents and other acquired technology	2.4		4
Trade names and trademarks(1)	14.2		n/a

(1)  Acquired trade names and trademarks associated with the Mactac acquisition were not subject to amortization as they were classified as indefinite-lived intangible assets.

Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

XML

Debt and Capital Leases

9 Months Ended

Oct. 01, 2016

Debt and Capital Leases

Debt and Capital Leases

Note 5.  Debt and Capital Leases

The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities on notes with similar rates, credit ratings, and remaining maturities. The fair value of short-term borrowings, which includes commercial paper issuances and short-term lines of credit, approximates carrying value given the short duration of these obligations.  The fair value of our total debt was $1.35 billion at October 1, 2016 and $1.08 billion at January 2, 2016. Fair value amounts were determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable.

Our $700 million revolving credit facility (the “Revolver”) contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of October 1, 2016 and January 2, 2016, we were in compliance with our financial covenants.

In March 2016, we entered into an agreement with three commercial paper dealers to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Proceeds from issuances under this program may be used for general corporate purposes. The maturities of the notes may vary, but may not exceed 364 days from the date of issuance. Our payment obligations with respect to any notes issued under this program would be backed by the Revolver. There are no financial covenants under this program. As of October 1, 2016, $210.3 million was outstanding under this program.

We reclassified approximately $250 million of senior notes due on October 1, 2017 from long-term debt to current portion of long-term debt.

XML

Pension and Other Postretirement Benefits

9 Months Ended

Oct. 01, 2016

Pension and Other Postretirement Benefits

Pension and Other Postretirement Benefits

Note 6.  Pension and Other Postretirement Benefits

Defined Benefit Plans

We sponsor a number of defined benefit plans, the accrual of benefits under some of which has been frozen, covering eligible employees in the U.S. and certain other countries.  Benefits payable to an employee are based primarily on years of service and the employee’s compensation during the course of his or her employment with us.

We are also obligated to pay unfunded termination indemnity benefits to certain employees outside of the U.S., which are subject to applicable agreements, laws and regulations.  We have not incurred significant costs related to these benefits, and therefore, no related costs are included in the disclosures below.

In December 2015, we offered eligible former employees who were vested participants in the Avery Dennison Pension Plan (“ADPP”), a U.S. pension plan, the opportunity to receive their benefits immediately as either a lump-sum payment or an annuity, rather than waiting until they are retirement eligible under the terms of the plan. In the second quarter of 2016, approximately $70 million of pension obligations related to this plan were settled out of existing plan assets and a non-cash pre-tax settlement charge of $41.4 million was recorded in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.  This settlement required us to remeasure the remaining net pension obligations of the ADPP. As a result, approximately $72 million of additional net pension obligations with a corresponding increase in actuarial losses recorded in “Accumulated other comprehensive loss” was recognized primarily due to lower discount rates that were in effect when the plan was remeasured.

The following table sets forth the components of net periodic benefit cost (credit), which was recorded in income from continuing operations, for our defined benefit plans:

	Pension Benefits
	Three Months Ended												Nine Months Ended
	October 1, 2016						October 3, 2015						October 1, 2016						October 3, 2015
(In millions)	U.S.			Int’l			U.S.			Int’l			U.S.			Int’l			U.S.			Int’l
Service cost	$	.1		$	3.5		$	.1		$	3.3		$	.3		$	10.4		$	.3		$	10.3
Interest cost	8.1			4.1			10.8			4.3			26.4			12.4			32.5			13.1
Actuarial loss	.7			–			–			–			2.4			–			–			–
Expected return on plan assets	(10.4		)	(5.4		)	(12.8		)	(5.4		)	(32.3		)	(16.1		)	(38.6		)	(16.2		)
Recognized net actuarial loss	4.9			1.7			5.2			2.4			14.1			5.3			15.4			7.2
Amortization of prior service cost (credit)	.3			–			.2			–			.9			(.2		)	.8			(.1		)
Recognized loss on settlements(1)	–			–			–			–			41.4			–			–			3.8
Net periodic benefit cost	$	3.7		$	3.9		$	3.5		$	4.6		$	53.2		$	11.8		$	10.4		$	18.1

(1)  In 2016, we recognized a loss on settlements related to our U.S. pension plan as a result of making the lump-sum pension payments described above; in 2015, we recognized a loss on settlements related to pension plans in Germany and France as a result of the sale of a product line in our RBIS reportable segment.  These losses on settlements were recorded in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

	U.S. Postretirement Health Benefits
	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Interest cost	$	–		$	.1		$	.1		$	.2
Recognized net actuarial loss	.5			.5			1.3			1.6
Amortization of prior service credit	(.9		)	(.8		)	(2.5		)	(2.4		)
Net periodic benefit credit	$	(.4	)	$	(.2	)	$	(1.1	)	$	(.6	)

XML

Research and Development

9 Months Ended

Oct. 01, 2016

Research and Development

Research and Development

Note 7.  Research and Development

Research and development expense from continuing operations was $22.4 million and $67.4 million for the three and nine months ended October 1, 2016, respectively, and $22.2 million and $70.6 million for the three and nine months ended October 3, 2015, respectively. This expense was included in “Marketing, general and administrative expense” in the unaudited Condensed Consolidated Statements of Income.

XML

Long-Term Incentive Compensation

9 Months Ended

Oct. 01, 2016

Long-Term Incentive Compensation

Long-Term Incentive Compensation

Note 8.  Long-Term Incentive Compensation

Equity Awards

Stock-based compensation expense from continuing operations was $6 million and $20.1 million for the three and nine months ended October 1, 2016, respectively, and $5.2 million and $18.4 million for the three and nine months ended October 3, 2015, respectively.  This expense was included in “Marketing, general and administrative expense” in the unaudited Condensed Consolidated Statements of Income.

As of October 1, 2016, we had approximately $44 million of unrecognized compensation expense from continuing operations related to unvested stock-based awards, which is expected to be recognized over the remaining weighted-average period of approximately two years.

Cash Awards

Compensation expense from continuing operations related to long-term incentive units was $7 million and $21.7 million for the three and nine months ended October 1, 2016, respectively, and $1.4 million and $16.7 million for the three and nine months ended October 3, 2015, respectively. This expense was included in “Marketing, general and administrative expense” in the unaudited Condensed Consolidated Statements of Income.

XML

Cost Reduction Actions

9 Months Ended

Oct. 01, 2016

Cost Reduction Actions

Cost Reduction Actions

Note 9.  Cost Reduction Actions

2015/2016 Actions

During the nine months ended October 1, 2016, we recorded $15 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015 that we expect to continue through 2016 (“2015/2016 Actions”). These charges consisted of severance and related costs for the reduction of approximately 310 positions, lease cancellation costs, and asset impairment charges.

During fiscal year 2015, we recorded $26.1 million in restructuring charges, net of reversals, related to our 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 430 positions, lease cancellation costs, and asset impairment charges.

No employees impacted by our 2015/2016 Actions taken through October 1, 2016 remained employed with us as of such date. We expect charges and payments related to these actions to be substantially completed in 2016.

2014/2015 Actions

During fiscal year 2015, we recorded $33.4 million in restructuring charges, net of reversals, related to restructuring actions we initiated in 2014 that continued through the second quarter of 2015 (“2014/2015 Actions”). These charges consisted of severance and related costs for the reduction of approximately 605 positions, lease cancellation costs, and asset impairment charges.

Approximately 25 employees impacted by our 2014/2015 Actions remained employed with us as of October 1, 2016. We expect charges and payments related to these actions to be substantially completed in 2016.

Accruals for severance and related costs and lease cancellation costs were included in “Other current liabilities” in the unaudited Condensed Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets, less selling costs, if applicable.  Restructuring charges were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

During the nine months ended October 1, 2016, restructuring charges and payments were as follows:

(In millions)	Accrual at January 2, 2016		Charges (Reversals), net			Cash Payments			Non-cash Impairment			Foreign Currency Translation		Accrual at October 1, 2016
2015/2016 Actions
Severance and related costs	$	8.4	$	11.1		$	(18.8	)	$	–		$	.2	$	.9
Asset impairment charges	–		2.9			–			(2.9		)	–		–
Lease cancellation costs	.2		1.0			(.8		)	–			–		.4
2014/2015 Actions
Severance and related costs	4.8		(.3		)	(3.3		)	–			–		1.2
Prior actions
Severance and related costs	.7		(.1		)	–			–			–		.6
Total	$	14.1	$	14.6		$	(22.9	)	$	(2.9	)	$	.2	$	3.1

The table below shows the total amount of restructuring charges incurred by reportable segment and Corporate:

	Three Months Ended				Nine Months Ended
(In millions)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
Restructuring charges by reportable segment and Corporate
Pressure-sensitive Materials	$	.7	$	1.1	$	7.5	$	15.5
Retail Branding and Information Solutions	1.5		3.7		6.6		19.4
Vancive Medical Technologies	.4		1.7		.5		3.4
Corporate	–		.1		–		2.2
	$	2.6	$	6.6	$	14.6	$	40.5

XML

Financial Instruments

9 Months Ended

Oct. 01, 2016

Financial Instruments

Financial Instruments

Note 10.  Financial Instruments

We enter into foreign exchange hedge contracts to reduce our risk from exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S.  We enter into interest rate contracts to help manage our exposure to certain interest rate fluctuations.  We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The maximum length of time for which we hedge our exposure to the variability in future cash flows for forecasted transactions is 36 months.

As of October 1, 2016, the aggregate U.S. dollar equivalent notional value of our outstanding commodity contracts and foreign exchange contracts was $2.3 million and $1.5 billion, respectively.

We recognize all derivative instruments as either assets or liabilities at fair value in the unaudited Condensed Consolidated Balance Sheets. We designate commodity forward contracts on forecasted purchases of commodities and foreign exchange contracts on forecasted transactions as cash flow hedges and designate foreign exchange contracts on existing balance sheet items as fair value hedges.

The following table provides the fair value and balance sheet locations of derivatives as of October 1, 2016:

	Asset			Liability
(In millions)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Other current assets	$	2.0	Other current liabilities	$	3.1
Commodity contracts	Other current assets	.1		Other current liabilities	–
		$	2.1		$	3.1

The following table provides the fair value and balance sheet locations of derivatives as of January 2, 2016:

	Asset			Liability
(In millions)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Other current assets	$	5.6	Other current liabilities	$	4.5
Commodity contracts	Other current assets	–		Other current liabilities	.7
		$	5.6		$	5.2

Fair Value Hedges

For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings, resulting in no material net impact to income.

The following table provides the components of net gains (losses) recognized in income related to fair value hedge contracts. The corresponding gains or losses on the underlying hedged items approximated the net gains (losses) on these fair value hedge contracts.

		Three Months Ended						Nine Months Ended
(In millions)	Location of Net Gains (Losses) in Income	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Foreign exchange contracts	Cost of products sold	$	(.2	)	$	2.3		$	1.5		$	3.3
Foreign exchange contracts	Marketing, general and administrative expense	(2.8		)	(19.9		)	(.4		)	(15.9		)
		$	(3.0	)	$	(17.6	)	$	1.1		$	(12.6	)

Cash Flow Hedges

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of “Accumulated other comprehensive loss” and reclassified into earnings in the same period(s) during which the hedged transaction impacts earnings.  Gains and losses on the derivative, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in current earnings.

Gains (losses) recognized in “Accumulated other comprehensive loss” (effective portion) on derivatives related to cash flow hedge contracts were as follows:

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Foreign exchange contracts	$	(1.3	)	$	2.7		$	(3.1	)	$	1.2
Commodity contracts	(.2		)	(1.7		)	.1			(.5		)
	$	(1.5	)	$	1.0		$	(3.0	)	$	.7

The amount of gain or loss recognized in income related to the ineffective portion of, and the amount excluded from, effectiveness testing for cash flow hedges and derivatives not designated as hedging instruments was not material for the three and nine months ended October 1, 2016 and October 3, 2015, respectively.

As of October 1, 2016, we expected a net loss of approximately $2 million to be reclassified from “Accumulated other comprehensive loss” to earnings within the next 12 months.  See Note 13, “Comprehensive Income,” for more information.

XML

Taxes Based on Income

9 Months Ended

Oct. 01, 2016

Taxes Based on Income

Taxes Based on Income

Note 11.  Taxes Based on Income

The following table summarizes our income from continuing operations before taxes, provision for income taxes from continuing operations, and effective tax rate:

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Provision for income taxes	38.9			34.8			92.1			99.5
Effective tax rate	30.4		%	30.0		%	26.3		%	31.3		%

The effective tax rate for continuing operations for the three and nine months ended October 1, 2016 reflected the impact of favorable geographic mixture of pretax income and included the following: $4.8 million and $3.1 million of tax expense, respectively, resulting from return to provision adjustments pursuant to the completion of the 2015 U.S. federal tax return; $1 million and $7.1 million of tax benefit, respectively, from our change in judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; and $17.7 million and $26.9 million of tax expense, respectively, associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries.  The effective tax rate for the three and nine months ended October 1, 2016 also included $11.1 million of tax benefit resulting from effective settlements of tax examinations in various foreign jurisdictions.  Included in the $11.1 million of tax benefit is an effective settlement for certain members of a consolidated tax group under examination. Additionally, the effective tax rate for the nine months ended October 1, 2016 included $6.7 million of tax benefit from the release of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority and $3.3 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years.

The effective tax rate for the nine months ended October 1, 2016 compared to the effective tax rate for the nine months ended October 3, 2015 was impacted by favorable effective settlements in various foreign jurisdictions, favorable geographic mixture of pretax income, and a tax benefit from the release of valuation allowances against deferred tax assets.

The effective tax rate for continuing operations for the three and nine months ended October 3, 2015 included $4.2 million of tax benefit resulting from return to provision adjustments pursuant to the completion of the 2014 U.S. federal tax return and $.9 million of tax benefit from a favorable foreign tax law change.  Additionally, the effective tax rate for the nine months ended October 3, 2015 included $1.6 million of net tax benefit related to changes in the effective tax rates in certain foreign municipalities; $4.2 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years; and $5.4 million of tax expense associated with the tax cost to repatriate non-permanently reinvested 2015 earnings of certain foreign subsidiaries.

The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world.  Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts, and circumstances existing at the time.  We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters.  However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate.  With some exceptions, we and our subsidiaries are no longer subject to income tax examinations by tax authorities for years prior to 2006.

It is reasonably possible that, during the next 12 months, we may realize a decrease in our uncertain tax positions, including interest and penalties, of approximately $26 million, primarily as a result of audit settlements and closing tax years.

XML

Net Income Per Common Share

9 Months Ended

Oct. 01, 2016

Net Income Per Common Share

Net Income Per Common Share

Note 12.  Net Income Per Common Share

Net income per common share was computed as follows:

	Three Months Ended				Nine Months Ended
(In millions, except per share amounts)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
(A) Income from continuing operations	$	89.1	$	81.3	$	258.7	$	217.9
(B) Income (loss) from discontinued operations	–		.4		–		(.6		)
(C) Net income available to common shareholders	$	89.1	$	81.7	$	258.7	$	217.3
(D) Weighted average number of common shares outstanding	89.1		91.5		89.2		91.1
Dilutive shares (additional common shares issuable under stock-based awards)	1.5		1.7		1.7		1.8
(E) Weighted average number of common shares outstanding, assuming dilution	90.6		93.2		90.9		92.9
Net income per common share:
Continuing operations (A) ÷ (D)	$	1.00	$	.89	$	2.90	$	2.39
Discontinued operations (B) ÷ (D)	–		–		–		–
Net income per common share (C) ÷ (D)	$	1.00	$	.89	$	2.90	$	2.39
Net income (loss) per common share, assuming dilution:
Continuing operations (A) ÷ (E)	$	.98	$	.87	$	2.85	$	2.35
Discontinued operations (B) ÷ (E)	–		.01		–		(.01		)
Net income per common share, assuming dilution (C) ÷ (E)	$	.98	$	.88	$	2.85	$	2.34

Certain stock-based compensation awards were not included in the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation totaled approximately .1 million shares and .2 million shares for the three and nine months ended October 1, 2016, respectively, and approximately .5 million and 1 million shares for the three and nine months ended October 3, 2015, respectively.

XML

Comprehensive Income

9 Months Ended

Oct. 01, 2016

Comprehensive Income

Comprehensive Income

Note 13.  Comprehensive Income

The changes in “Accumulated other comprehensive loss” (net of tax) for the nine months ended October 1, 2016 were as follows:

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total
Balance as of January 2, 2016	$	(158.9	)	$	(521.6	)	$	(2.5	)	$	(683.0	)
Other comprehensive income (loss) before reclassifications, net of tax	21.1			(46.7		)	(2.2		)	(27.8		)
Reclassifications to net income, net of tax	–			39.8			2.0			41.8
Net current-period other comprehensive income (loss), net of tax	21.1			(6.9		)	(.2		)	14.0
Balance as of October 1, 2016	$	(137.8	)	$	(528.5	)	$	(2.7	)	$	(669.0	)

The changes in “Accumulated other comprehensive loss” (net of tax) for the nine months ended October 3, 2015 were as follows:

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total
Balance as of January 3, 2015	$	(19.9	)	$	(525.6	)	$	–		$	(545.5	)
Other comprehensive (loss) income before reclassifications, net of tax	(129.6		)	(.5		)	.6			(129.5		)
Reclassifications to net income, net of tax	–			18.2			(1.4		)	16.8
Net current-period other comprehensive (loss) income, net of tax	(129.6		)	17.7			(.8		)	(112.7		)
Balance as of October 3, 2015	$	(149.5	)	$	(507.9	)	$	(.8	)	$	(658.2	)

The amounts reclassified from “Accumulated other comprehensive loss” to increase (decrease) income from continuing operations were as follows:

	Amounts Reclassified from Accumulated Other Comprehensive Loss
	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015			Affected Line Item in the Statements Where Net Income is Presented
Cash flow hedges:
Foreign exchange contracts	$	(1.2	)	$	1.4		$	(2.1	)	$	2.7		Cost of products sold
Commodity contracts	–			(.1		)	(.6		)	(.9		)	Cost of products sold
Interest rate contracts	(.1		)	(.1		)	(.1		)	(.1		)	Interest expense
	(1.3		)	1.2			(2.8		)	1.7			Total before tax
	.4			(.2		)	.8			(.3		)	Provision for income taxes
	(.9		)	1.0			(2.0		)	1.4			Net of tax
Pension and other postretirement benefits(1)	(6.5		)	(7.5		)	(60.3		)	(26.3		)
	2.1			2.4			20.5			8.1			Provision for income taxes
	(4.4		)	(5.1		)	(39.8		)	(18.2		)	Net of tax
Total reclassifications for the period	$	(5.3	)	$	(4.1	)	$	(41.8	)	$	(16.8	)	Total, net of tax

⁽¹⁾ See Note 6, “Pension and Other Postretirement Benefits,” for more information.

The following table sets forth the income tax expense (benefit) allocated to each component of other comprehensive income (loss):

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Pension and other postretirement benefits	$	2.0		$	2.4		$	(4.7	)	$	9.1
Cash flow hedges	(.1		)	(.1		)	–			(.2		)
Income tax expense (benefit) related to components of other comprehensive income (loss)	$	1.9		$	2.3		$	(4.7	)	$	8.9

XML

Fair Value Measurements

9 Months Ended

Oct. 01, 2016

Fair Value Measurements

Fair Value Measurements

Note 14.  Fair Value Measurements

Recurring Fair Value Measurements

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of October 1, 2016:

			Fair Value Measurements Using
(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets
Trading securities	$	18.9	$	12.7	$	6.2	$	–
Derivative assets	2.1		.1		2.0		–
Bank drafts	15.9		15.9		–		–
Liabilities
Derivative liabilities	$	3.1	$	–	$	3.1	$	–

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of January 2, 2016:

			Fair Value Measurements Using
(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets
Trading securities	$	17.9	$	11.3	$	6.6	$	–
Derivative assets	5.6		–		5.6		–
Bank drafts	24.8		24.8		–		–
Liabilities
Derivative liabilities	$	5.2	$	.7	$	4.5	$	–

Trading securities include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value.  As of October 1, 2016, trading securities of $.4 million and $18.5 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets. As of January 2, 2016, trading securities of $.3 million and $17.6 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets.  Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy.  Derivatives measured based on foreign exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than three months) are valued at face value due to their short-term nature and were included in “Other current assets” in the unaudited Condensed Consolidated Balance Sheets.

We utilized an income approach to estimate the fair values of the identifiable intangibles acquired from Mactac, using primarily Level 3 inputs. The discount rates we used to value these assets were between 10% and 12%.

XML

Commitments and Contingencies

9 Months Ended

Oct. 01, 2016

Commitments and Contingencies

Commitments and Contingencies

Note 15.  Commitments and Contingencies

Legal Proceedings

We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business.  We have accrued liabilities for matters where it is probable that a loss will be incurred and the amount of loss can be reasonably estimated.  Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses.  If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly.  Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future.  The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.

Environmental

As of October 1, 2016, we have been designated by the U.S. Environmental Protection Agency (“EPA”) and/or other responsible state agencies as a potentially responsible party (“PRP”) at thirteen waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination.  No settlement of our liability related to any of the sites has been agreed upon.  We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.

We have accrued liabilities for sites where it is probable that a loss or cost will be incurred and the amount of loss or cost can be reasonably estimated.  These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors.  Because of the uncertainties associated with environmental assessment and remediation activities, future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses.  If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly.  In addition, we may be identified as a PRP at additional sites in the future.  The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.

The activity for the nine months ended October 1, 2016 related to our environmental liabilities was as follows:

(In millions)
Balance at January 2, 2016	$	17.7
Charges (reversals), net	6.1
Payments	(5.9		)
Balance at October 1, 2016	$	17.9

As of October 1, 2016 and January 2, 2016, approximately $9 million and $7 million, respectively, of the balance was classified as short-term and included in “Other current liabilities” in the unaudited Condensed Consolidated Balance Sheets.

XML

Segment Information

9 Months Ended

Oct. 01, 2016

Segment Information

Segment Information

Note 16.  Segment Information

Financial information from continuing operations by reportable segment is set forth below:

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Net sales to unaffiliated customers
Pressure-sensitive Materials	$	1,123.8		$	1,083.7		$	3,360.9		$	3,318.4
Retail Branding and Information Solutions	370.9			366.8			1,127.0			1,138.7
Vancive Medical Technologies	14.0			17.6			47.8			55.0
Net sales to unaffiliated customers	$	1,508.7		$	1,468.1		$	4,535.7		$	4,512.1
Intersegment sales
Pressure-sensitive Materials	$	16.3		$	14.6		$	49.0		$	46.5
Retail Branding and Information Solutions	.5			.3			1.6			1.5
Vancive Medical Technologies	.1			1.2			.4			4.4
Intersegment sales	$	16.9		$	16.1		$	51.0		$	52.4
Income from continuing operations before taxes
Pressure-sensitive Materials	$	138.7		$	130.5		$	425.6		$	383.2
Retail Branding and Information Solutions	28.4			25.1			82.8			54.3
Vancive Medical Technologies	(.9		)	(1.2		)	(.2		)	(4.7		)
Corporate expense	(23.5		)	(23.6		)	(112.0		)	(70.1		)
Interest expense	(14.7		)	(14.7		)	(45.4		)	(45.3		)
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Other expense, net by reportable segment
Pressure-sensitive Materials	$	2.7		$	1.1		$	11.2		$	13.8
Retail Branding and Information Solutions	1.5			3.9			7.3			29.4
Vancive Medical Technologies	.4			1.7			.5			3.4
Corporate	–			.3			41.4			2.4
Other expense, net	$	4.6		$	7.0		$	60.4		$	49.0
Other expense, net by type
Restructuring charges:
Severance and related costs	$	1.9		$	4.7		$	10.7		$	35.0
Asset impairment charges and lease cancellation costs	.7			1.9			3.9			5.5
Other items:
Loss from settlement of pension obligations	–			–			41.4			–
Transaction costs	2.0			–			4.1			–
Loss (gain) on sale of assets	–			–			.3			(1.7		)
Loss on sale of product line and related transaction and exit costs	–			.2			–			10.5
Legal settlements	–			.2			–			(.3		)
Other expense, net	$	4.6		$	7.0		$	60.4		$	49.0

XML

Recent Accounting Requirements

9 Months Ended

Oct. 01, 2016

Recent Accounting Requirements

Recent Accounting Requirements

Note 17.  Recent Accounting Requirements

In August 2016, the Financial Accounting Standards Board (“FASB”) issued guidance to reduce the diversity in the presentation of certain cash receipts and cash payments presented and classified in the statement of cash flows.  This guidance requires retrospective adoption and will be effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is permitted. We are currently assessing the impact of this guidance on our cash flows.

In March 2016, the FASB issued guidance to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance will be effective for fiscal years and interim periods beginning after December 15, 2016, and early adoption is permitted. Different components of the guidance require prospective, retrospective and/or modified retrospective adoption. We are currently assessing the timing of our adoption of this guidance and its impact on our financial position, results of operations, cash flows, and disclosures.

In March 2016, the FASB issued guidance on accounting for leases that requires lessees to recognize most leases on their balance sheets for the rights and obligations created by those leases. This guidance also requires enhanced disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases and will be effective for interim and annual periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective approach is required for adoption with respect to all leases that exist at or commence after the date of initial application with an option to use certain practical expedients. We are currently assessing the impact of this guidance on our financial position, results of operations, cash flows, and disclosures.

In July 2015, the FASB issued amended guidance to simplify the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value.  Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. This guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those fiscal years. We elected to early adopt this amended guidance in the first quarter of 2016 prospectively. The adoption of this guidance did not have an impact on our financial position, results of operations, cash flows, or disclosures.

In August 2014, the FASB issued a new standard that requires an entity to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern.  Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Under this new standard, substantial doubt exists when it is probable that the entity will be unable to meet its obligations as they become due within one year of the date the financial statements are issued.  If applicable, certain disclosures are required, including management’s plans to mitigate those relevant conditions or events to alleviate the substantial doubt.  This standard is effective for annual periods and interim periods within those annual periods ending after December 15, 2016.  Early adoption is permitted. We do not expect that adoption of this standard will have an impact on our financial position, results of operations, cash flows, or disclosures.

In May 2014, and in subsequent updates, the FASB issued revised guidance on revenue recognition. This revised guidance provides a single comprehensive model for accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This revised guidance will require an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This update creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which includes (i) identifying the contract(s) with the customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv) allocating the transaction price to the separate performance obligations, and (v) recognizing revenue when each performance obligation is satisfied. This revised guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This revised guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years, and can be applied retrospectively either to each prior reporting period presented or with the cumulative effect of adoption recognized at the date of initial application. Early adoption is permitted for fiscal periods beginning after December 15, 2016. We are currently evaluating which transition method to elect and we expect to adopt this guidance in the first quarter of 2018. Based on the information we have evaluated to date, we do not anticipate that the adoption of this revised guidance will have a significant impact on our financial position, results of operations, or cash flows.

XML

General (Policies)

9 Months Ended

Oct. 01, 2016

General

Fiscal Periods

Fiscal Periods

The third quarters of 2016 and 2015 consisted of thirteen-week periods ending October 1, 2016 and October 3, 2015, respectively. The nine months ended October 1, 2016 and October 3, 2015 each consisted of thirty-nine-week periods.

XML

General (Tables)

9 Months Ended

Oct. 01, 2016

General

Summary of Previously Stated and Corrected Balance of Condensed Consolidated Statements of Cash Flows

	Nine Months Ended October 3, 2015
(In millions)	As Previously Reported			Adjustment			As Revised
Net cash provided by operating activities	$	290.3		$	(8.1	)	$	282.2
Decrease in cash and cash equivalents	(55.3		)	(8.1		)	(63.4		)
Cash and cash equivalents, beginning of year	227.0			(19.8		)	207.2
Cash and cash equivalents, end of period	171.7			(27.9		)	143.8

XML

Inventories (Tables)

9 Months Ended

Oct. 01, 2016

Inventories

Net inventories

(In millions)	October 1, 2016		January 2, 2016
Raw materials	$	207.8	$	180.5
Work-in-progress	172.1		143.0
Finished goods	185.4		155.2
Inventories, net	$	565.3	$	478.7

XML

Goodwill and Other Intangibles Resulting from Business Acquisitions (Tables)

9 Months Ended

Oct. 01, 2016

Goodwill and Other Intangibles Resulting from Business Acquisitions

Changes in net carrying amount of goodwill

(In millions)	Pressure-sensitive Materials		Retail Branding and Information Solutions		Total
Goodwill as of January 2, 2016	$	277.9	$	408.3	$	686.2
Acquired during current period(1)	125.0		–		125.0
Translation adjustments	7.2		3.2		10.4
Goodwill as of October 1, 2016	$	410.1	$	411.5	$	821.6

(1)   Goodwill acquired during the current period primarily related to the Mactac acquisition.

Summary of weighted-average amortization periods from the date of acquisition and weighted-average remaining useful lives of finite-lived intangible assets

	Amount (in millions)		Weighted-average amortization period (in years)
Customer relationships	$	22.8		15
Patents and other acquired technology	2.4		4
Trade names and trademarks(1)	14.2		n/a

(1)  Acquired trade names and trademarks associated with the Mactac acquisition were not subject to amortization as they were classified as indefinite-lived intangible assets.

XML

Pension and Other Postretirement Benefits (Tables)

9 Months Ended

Oct. 01, 2016

Pension and Other Postretirement Benefits

Schedule of components of net periodic benefit cost (credit)

	Pension Benefits
	Three Months Ended												Nine Months Ended
	October 1, 2016						October 3, 2015						October 1, 2016						October 3, 2015
(In millions)	U.S.			Int’l			U.S.			Int’l			U.S.			Int’l			U.S.			Int’l
Service cost	$	.1		$	3.5		$	.1		$	3.3		$	.3		$	10.4		$	.3		$	10.3
Interest cost	8.1			4.1			10.8			4.3			26.4			12.4			32.5			13.1
Actuarial loss	.7			–			–			–			2.4			–			–			–
Expected return on plan assets	(10.4		)	(5.4		)	(12.8		)	(5.4		)	(32.3		)	(16.1		)	(38.6		)	(16.2		)
Recognized net actuarial loss	4.9			1.7			5.2			2.4			14.1			5.3			15.4			7.2
Amortization of prior service cost (credit)	.3			–			.2			–			.9			(.2		)	.8			(.1		)
Recognized loss on settlements(1)	–			–			–			–			41.4			–			–			3.8
Net periodic benefit cost	$	3.7		$	3.9		$	3.5		$	4.6		$	53.2		$	11.8		$	10.4		$	18.1

(1)  In 2016, we recognized a loss on settlements related to our U.S. pension plan as a result of making the lump-sum pension payments described above; in 2015, we recognized a loss on settlements related to pension plans in Germany and France as a result of the sale of a product line in our RBIS reportable segment.  These losses on settlements were recorded in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income.

	U.S. Postretirement Health Benefits
	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Interest cost	$	–		$	.1		$	.1		$	.2
Recognized net actuarial loss	.5			.5			1.3			1.6
Amortization of prior service credit	(.9		)	(.8		)	(2.5		)	(2.4		)
Net periodic benefit credit	$	(.4	)	$	(.2	)	$	(1.1	)	$	(.6	)

XML

Cost Reduction Actions (Tables)

9 Months Ended

Oct. 01, 2016

Cost Reduction Actions

Restructuring charges and payments

(In millions)	Accrual at January 2, 2016		Charges (Reversals), net			Cash Payments			Non-cash Impairment			Foreign Currency Translation		Accrual at October 1, 2016
2015/2016 Actions
Severance and related costs	$	8.4	$	11.1		$	(18.8	)	$	–		$	.2	$	.9
Asset impairment charges	–		2.9			–			(2.9		)	–		–
Lease cancellation costs	.2		1.0			(.8		)	–			–		.4
2014/2015 Actions
Severance and related costs	4.8		(.3		)	(3.3		)	–			–		1.2
Prior actions
Severance and related costs	.7		(.1		)	–			–			–		.6
Total	$	14.1	$	14.6		$	(22.9	)	$	(2.9	)	$	.2	$	3.1

Total amount of restructuring charges incurred by reportable segment and Corporate

	Three Months Ended				Nine Months Ended
(In millions)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
Restructuring charges by reportable segment and Corporate
Pressure-sensitive Materials	$	.7	$	1.1	$	7.5	$	15.5
Retail Branding and Information Solutions	1.5		3.7		6.6		19.4
Vancive Medical Technologies	.4		1.7		.5		3.4
Corporate	–		.1		–		2.2
	$	2.6	$	6.6	$	14.6	$	40.5

XML

Financial Instruments (Tables)

9 Months Ended

Oct. 01, 2016

Financial Instruments

Fair value and balance sheet locations of derivatives

The following table provides the fair value and balance sheet locations of derivatives as of October 1, 2016:

	Asset			Liability
(In millions)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Other current assets	$	2.0	Other current liabilities	$	3.1
Commodity contracts	Other current assets	.1		Other current liabilities	–
		$	2.1		$	3.1

The following table provides the fair value and balance sheet locations of derivatives as of January 2, 2016:

	Asset			Liability
(In millions)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Other current assets	$	5.6	Other current liabilities	$	4.5
Commodity contracts	Other current assets	–		Other current liabilities	.7
		$	5.6		$	5.2

Components of net gains (losses) recognized in income related to fair value hedge contracts

		Three Months Ended						Nine Months Ended
(In millions)	Location of Net Gains (Losses) in Income	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Foreign exchange contracts	Cost of products sold	$	(.2	)	$	2.3		$	1.5		$	3.3
Foreign exchange contracts	Marketing, general and administrative expense	(2.8		)	(19.9		)	(.4		)	(15.9		)
		$	(3.0	)	$	(17.6	)	$	1.1		$	(12.6	)

Components of the gains (losses) recognized in Accumulated other comprehensive loss related to cash flow hedges

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Foreign exchange contracts	$	(1.3	)	$	2.7		$	(3.1	)	$	1.2
Commodity contracts	(.2		)	(1.7		)	.1			(.5		)
	$	(1.5	)	$	1.0		$	(3.0	)	$	.7

XML

Taxes Based on Income (Tables)

9 Months Ended

Oct. 01, 2016

Taxes Based on Income

Income before taxes, provision for income taxes, and effective tax rate from continuing operations

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Provision for income taxes	38.9			34.8			92.1			99.5
Effective tax rate	30.4		%	30.0		%	26.3		%	31.3		%

XML

Net Income Per Common Share (Tables)

9 Months Ended

Oct. 01, 2016

Net Income Per Common Share

Schedule of net income per common share

	Three Months Ended				Nine Months Ended
(In millions, except per share amounts)	October 1, 2016		October 3, 2015		October 1, 2016		October 3, 2015
(A) Income from continuing operations	$	89.1	$	81.3	$	258.7	$	217.9
(B) Income (loss) from discontinued operations	–		.4		–		(.6		)
(C) Net income available to common shareholders	$	89.1	$	81.7	$	258.7	$	217.3
(D) Weighted average number of common shares outstanding	89.1		91.5		89.2		91.1
Dilutive shares (additional common shares issuable under stock-based awards)	1.5		1.7		1.7		1.8
(E) Weighted average number of common shares outstanding, assuming dilution	90.6		93.2		90.9		92.9
Net income per common share:
Continuing operations (A) ÷ (D)	$	1.00	$	.89	$	2.90	$	2.39
Discontinued operations (B) ÷ (D)	–		–		–		–
Net income per common share (C) ÷ (D)	$	1.00	$	.89	$	2.90	$	2.39
Net income (loss) per common share, assuming dilution:
Continuing operations (A) ÷ (E)	$	.98	$	.87	$	2.85	$	2.35
Discontinued operations (B) ÷ (E)	–		.01		–		(.01		)
Net income per common share, assuming dilution (C) ÷ (E)	$	.98	$	.88	$	2.85	$	2.34

XML

Comprehensive Income (Tables)

9 Months Ended

Oct. 01, 2016

Comprehensive Income

Schedule of changes in "Accumulated other comprehensive loss" (net of tax)

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total
Balance as of January 2, 2016	$	(158.9	)	$	(521.6	)	$	(2.5	)	$	(683.0	)
Other comprehensive income (loss) before reclassifications, net of tax	21.1			(46.7		)	(2.2		)	(27.8		)
Reclassifications to net income, net of tax	–			39.8			2.0			41.8
Net current-period other comprehensive income (loss), net of tax	21.1			(6.9		)	(.2		)	14.0
Balance as of October 1, 2016	$	(137.8	)	$	(528.5	)	$	(2.7	)	$	(669.0	)

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total
Balance as of January 3, 2015	$	(19.9	)	$	(525.6	)	$	–		$	(545.5	)
Other comprehensive (loss) income before reclassifications, net of tax	(129.6		)	(.5		)	.6			(129.5		)
Reclassifications to net income, net of tax	–			18.2			(1.4		)	16.8
Net current-period other comprehensive (loss) income, net of tax	(129.6		)	17.7			(.8		)	(112.7		)
Balance as of October 3, 2015	$	(149.5	)	$	(507.9	)	$	(.8	)	$	(658.2	)

Schedule of amounts reclassified from "Accumulated other comprehensive loss" to increase (decrease) income from continuing operations

	Amounts Reclassified from Accumulated Other Comprehensive Loss
	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015			Affected Line Item in the Statements Where Net Income is Presented
Cash flow hedges:
Foreign exchange contracts	$	(1.2	)	$	1.4		$	(2.1	)	$	2.7		Cost of products sold
Commodity contracts	–			(.1		)	(.6		)	(.9		)	Cost of products sold
Interest rate contracts	(.1		)	(.1		)	(.1		)	(.1		)	Interest expense
	(1.3		)	1.2			(2.8		)	1.7			Total before tax
	.4			(.2		)	.8			(.3		)	Provision for income taxes
	(.9		)	1.0			(2.0		)	1.4			Net of tax
Pension and other postretirement benefits(1)	(6.5		)	(7.5		)	(60.3		)	(26.3		)
	2.1			2.4			20.5			8.1			Provision for income taxes
	(4.4		)	(5.1		)	(39.8		)	(18.2		)	Net of tax
Total reclassifications for the period	$	(5.3	)	$	(4.1	)	$	(41.8	)	$	(16.8	)	Total, net of tax

⁽¹⁾ See Note 6, “Pension and Other Postretirement Benefits,” for more information.

Income tax (benefit) expense allocated to each component of other comprehensive (loss) income

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Pension and other postretirement benefits	$	2.0		$	2.4		$	(4.7	)	$	9.1
Cash flow hedges	(.1		)	(.1		)	–			(.2		)
Income tax expense (benefit) related to components of other comprehensive income (loss)	$	1.9		$	2.3		$	(4.7	)	$	8.9

XML

Fair Value Measurements (Tables)

9 Months Ended

Oct. 01, 2016

Fair Value Measurements

Assets and liabilities carried at fair value, measured on a recurring basis

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of October 1, 2016:

			Fair Value Measurements Using
(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets
Trading securities	$	18.9	$	12.7	$	6.2	$	–
Derivative assets	2.1		.1		2.0		–
Bank drafts	15.9		15.9		–		–
Liabilities
Derivative liabilities	$	3.1	$	–	$	3.1	$	–

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of January 2, 2016:

			Fair Value Measurements Using
(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets
Trading securities	$	17.9	$	11.3	$	6.6	$	–
Derivative assets	5.6		–		5.6		–
Bank drafts	24.8		24.8		–		–
Liabilities
Derivative liabilities	$	5.2	$	.7	$	4.5	$	–

XML

Commitments and Contingencies (Tables)

9 Months Ended

Oct. 01, 2016

Commitments and Contingencies

Costs of environmental liabilities with remediation

(In millions)
Balance at January 2, 2016	$	17.7
Charges (reversals), net	6.1
Payments	(5.9		)
Balance at October 1, 2016	$	17.9

XML

Segment Information (Tables)

9 Months Ended

Oct. 01, 2016

Segment Information

Financial information, by reportable segment from continuing operations

	Three Months Ended						Nine Months Ended
(In millions)	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Net sales to unaffiliated customers
Pressure-sensitive Materials	$	1,123.8		$	1,083.7		$	3,360.9		$	3,318.4
Retail Branding and Information Solutions	370.9			366.8			1,127.0			1,138.7
Vancive Medical Technologies	14.0			17.6			47.8			55.0
Net sales to unaffiliated customers	$	1,508.7		$	1,468.1		$	4,535.7		$	4,512.1
Intersegment sales
Pressure-sensitive Materials	$	16.3		$	14.6		$	49.0		$	46.5
Retail Branding and Information Solutions	.5			.3			1.6			1.5
Vancive Medical Technologies	.1			1.2			.4			4.4
Intersegment sales	$	16.9		$	16.1		$	51.0		$	52.4
Income from continuing operations before taxes
Pressure-sensitive Materials	$	138.7		$	130.5		$	425.6		$	383.2
Retail Branding and Information Solutions	28.4			25.1			82.8			54.3
Vancive Medical Technologies	(.9		)	(1.2		)	(.2		)	(4.7		)
Corporate expense	(23.5		)	(23.6		)	(112.0		)	(70.1		)
Interest expense	(14.7		)	(14.7		)	(45.4		)	(45.3		)
Income from continuing operations before taxes	$	128.0		$	116.1		$	350.8		$	317.4
Other expense, net by reportable segment
Pressure-sensitive Materials	$	2.7		$	1.1		$	11.2		$	13.8
Retail Branding and Information Solutions	1.5			3.9			7.3			29.4
Vancive Medical Technologies	.4			1.7			.5			3.4
Corporate	–			.3			41.4			2.4
Other expense, net	$	4.6		$	7.0		$	60.4		$	49.0
Other expense, net by type
Restructuring charges:
Severance and related costs	$	1.9		$	4.7		$	10.7		$	35.0
Asset impairment charges and lease cancellation costs	.7			1.9			3.9			5.5
Other items:
Loss from settlement of pension obligations	–			–			41.4			–
Transaction costs	2.0			–			4.1			–
Loss (gain) on sale of assets	–			–			.3			(1.7		)
Loss on sale of product line and related transaction and exit costs	–			.2			–			10.5
Legal settlements	–			.2			–			(.3		)
Other expense, net	$	4.6		$	7.0		$	60.4		$	49.0

XML

General (Details)	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
General
Length of fiscal period	91 days	91 days	273 days	273 days

XML

General - Condensed Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015
Accounting Changes and Error Corrections
Net cash provided by operating activities	$ 365.7	$ 282.2
Increase (decrease) in cash and cash equivalents	30.6	(63.4)
Cash and cash equivalents, beginning of year	158.8	207.2
Cash and cash equivalents, end of period	$ 189.4	143.8
As Previously Reported
Accounting Changes and Error Corrections
Net cash provided by operating activities		290.3
Increase (decrease) in cash and cash equivalents		(55.3)
Cash and cash equivalents, beginning of year		227.0
Cash and cash equivalents, end of period		171.7
Adjustment
Accounting Changes and Error Corrections
Net cash provided by operating activities		(8.1)
Increase (decrease) in cash and cash equivalents		(8.1)
Cash and cash equivalents, beginning of year		(19.8)
Cash and cash equivalents, end of period		$ (27.9)

XML

General - Sale of Product Line and Discontinued Operations (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	May 31, 2015	Oct. 03, 2015	Apr. 04, 2015	Oct. 03, 2015
Discontinued Operations
Loss on sale of product line and related exit costs		$ 0.2		$ 10.5
Retail Branding and Information Solutions
Discontinued Operations
Proceeds from sale of product line	$ 1.5
Loss on sale of product line and related exit costs	$ 8.5
Impairment of long-lived assets of product line			$ 2.0
Other costs related to sale of product line			$ 0.6

XML

Acquisitions (Details) $ in Millions	Aug. 01, 2016 USD ($)
Mactac Acquisition
Business Acquisition
Purchase price	$ 222

XML

Inventories (Details) - USD ($) $ in Millions	Oct. 01, 2016	Jan. 02, 2016
Inventories
Raw materials	$ 207.8	$ 180.5
Work-in-progress	172.1	143.0
Finished goods	185.4	155.2
Inventories, net	$ 565.3	$ 478.7

XML

Goodwill and Other Intangibles Resulting from Business Acquisitions (Details) - USD ($) $ in Millions		9 Months Ended
	Oct. 01, 2016	Oct. 01, 2016	Jan. 02, 2016
Changes in net carrying amount of goodwill
Goodwill, Beginning Balance		$ 686.2
Acquired during current period		125.0
Translation adjustments		10.4
Goodwill, Ending Balance	$ 821.6	821.6
Mactac Acquisition
Changes in net carrying amount of goodwill
Goodwill, Ending Balance	120.0	120.0
Finite Lived And Indefinite Lived Intangible Assets Acquired
Intangible assets acquired	39.0	39.0
Customer relationships
Acquired Finite-Lived Intangible Assets
Intangible assets acquired	$ 22.8
Weighted-average useful life	15 years
Patents and other acquired technology
Acquired Finite-Lived Intangible Assets
Intangible assets acquired	$ 2.4
Weighted-average useful life	4 years
Trade names and trademarks
Indefinite-lived Intangible Assets
Intangible assets acquired	$ 14.2
Pressure-sensitive Materials
Changes in net carrying amount of goodwill
Goodwill, Beginning Balance		277.9
Acquired during current period		125.0
Translation adjustments		7.2
Goodwill, Ending Balance	410.1	410.1
Retail Branding and Information Solutions
Changes in net carrying amount of goodwill
Goodwill, Beginning Balance		408.3
Translation adjustments		3.2
Goodwill, Ending Balance	411.5	411.5
Accumulated impairment losses	820.0	820.0	$ 820.0
Vancive Medical Technologies
Changes in net carrying amount of goodwill
Goodwill, Ending Balance	$ 0.0	$ 0.0

XML

Debt and Capital Leases (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Oct. 01, 2016	Jan. 02, 2016	Apr. 02, 2016
Debt
Fair value of debt	$ 1,350.0	$ 1,080.0
Long-term debt, current	250.0
Revolving credit facility
Debt
Maximum borrowing capacity	$ 700.0
Covenants compliance	we were in compliance with our financial covenants.	we were in compliance with our financial covenants.
Commercial Paper
Debt
Maximum borrowing capacity			$ 500.0
Amount outstanding	$ 210.3

XML

Pension and Other Postretirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Oct. 01, 2016	Jul. 02, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Components of net periodic benefit cost (credit)
Actuarial loss		$ 72.0
Recognized loss on settlements				$ 41.4
U.S.
Defined Benefit Plans
Settled pension obligation		70.0
Components of net periodic benefit cost (credit)
Recognized loss on settlements		$ 41.4
U.S. | Continuing operations
Components of net periodic benefit cost (credit)
Service cost	$ 0.1		$ 0.1	0.3	$ 0.3
Interest cost	8.1		10.8	26.4	32.5
Actuarial loss	0.7			2.4
Expected return on plan assets	(10.4)		(12.8)	(32.3)	(38.6)
Recognized net actuarial loss	4.9		5.2	14.1	15.4
Amortization of prior service cost (credit)	0.3		0.2	0.9	0.8
Recognized loss on settlements				41.4
Net periodic benefit cost (credit)	3.7		3.5	53.2	10.4
Int'l | Continuing operations
Components of net periodic benefit cost (credit)
Service cost	3.5		3.3	10.4	10.3
Interest cost	4.1		4.3	12.4	13.1
Expected return on plan assets	(5.4)		(5.4)	(16.1)	(16.2)
Recognized net actuarial loss	1.7		2.4	5.3	7.2
Amortization of prior service cost (credit)				(0.2)	(0.1)
Recognized loss on settlements					3.8
Net periodic benefit cost (credit)	3.9		4.6	11.8	18.1
U.S. Postretirement Health Benefits | Continuing operations
Components of net periodic benefit cost (credit)
Interest cost			0.1	0.1	0.2
Recognized net actuarial loss	0.5		0.5	1.3	1.6
Amortization of prior service cost (credit)	(0.9)		(0.8)	(2.5)	(2.4)
Net periodic benefit cost (credit)	$ (0.4)		$ (0.2)	$ (1.1)	$ (0.6)

XML

Research and Development (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Marketing, general and administrative expense
Research and development expense	$ 22.4	$ 22.2	$ 67.4	$ 70.6

XML

Long-Term Incentive Compensation (Details) - Continuing operations - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Marketing, general and administrative expense
Stock-Based Compensation
Stock-based compensation expense	$ 6.0	$ 5.2	$ 20.1	$ 18.4
Cash-Based LTI Compensation
Cash-based LTI awards compensation expense	7.0	$ 1.4	21.7	$ 16.7
Stock-based awards
Stock-Based Compensation
Unrecognized compensation cost related to share based compensation cost	$ 44.0		$ 44.0
Unrecognized compensation cost weighted average recognition period			2 years

XML

Cost Reduction Actions (Details) $ in Millions	9 Months Ended	12 Months Ended
	Oct. 01, 2016 USD ($) item	Jan. 02, 2016 USD ($) item
Restructuring Charges
Charges (Reversals), net | $	$ 14.6
2015/2016 Actions
Restructuring Charges
Charges (Reversals), net | $	$ 15.0	$ 26.1
Number of positions reduced as a result of Cost Reduction Actions	310	430
Number of positions remaining	0
2014/2015 Actions
Restructuring Charges
Charges (Reversals), net | $		$ 33.4
Number of positions reduced as a result of Cost Reduction Actions		605
Number of positions remaining	25

XML

Cost Reduction Actions - Restructuring Charges and Payments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015	Jan. 02, 2016
Cost Reduction Actions
Beginning Balance			$ 14.1
Charges (Reversals), net			14.6
Cash Payments			(22.9)
Non-cash Impairment			(2.9)
Foreign Currency Translation			0.2
Ending Balance	$ 3.1		3.1		$ 14.1
Severance and related costs
Cost Reduction Actions
Charges (Reversals), net	1.9	$ 4.7	10.7	$ 35.0
2015/2016 Actions
Cost Reduction Actions
Charges (Reversals), net			15.0		26.1
2015/2016 Actions | Severance and related costs
Cost Reduction Actions
Beginning Balance			8.4
Charges (Reversals), net			11.1
Cash Payments			(18.8)
Foreign Currency Translation			0.2
Ending Balance	0.9		0.9		8.4
2015/2016 Actions | Asset impairment charges
Cost Reduction Actions
Charges (Reversals), net			2.9
Non-cash Impairment			(2.9)
2015/2016 Actions | Lease cancellation costs
Cost Reduction Actions
Beginning Balance			0.2
Charges (Reversals), net			1.0
Cash Payments			(0.8)
Ending Balance	0.4		0.4		0.2
2014/2015 Actions
Cost Reduction Actions
Charges (Reversals), net					33.4
2014/2015 Actions | Severance and related costs
Cost Reduction Actions
Beginning Balance			4.8
Charges (Reversals), net			(0.3)
Cash Payments			(3.3)
Ending Balance	1.2		1.2		4.8
Prior actions | Severance and related costs
Cost Reduction Actions
Beginning Balance			0.7
Charges (Reversals), net			(0.1)
Ending Balance	$ 0.6		$ 0.6		$ 0.7

XML

Cost Reduction Actions - Reportable Segment and Corporate (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Restructuring Charges
Restructuring charges			$ 14.6
Other expense, net.
Restructuring Charges
Restructuring charges	$ 2.6	$ 6.6	14.6	$ 40.5
Pressure-sensitive Materials | Other expense, net.
Restructuring Charges
Restructuring charges	0.7	1.1	7.5	15.5
Retail Branding and Information Solutions | Other expense, net.
Restructuring Charges
Restructuring charges	1.5	3.7	6.6	19.4
Vancive Medical Technologies | Other expense, net.
Restructuring Charges
Restructuring charges	$ 0.4	1.7	$ 0.5	3.4
Corporate | Other expense, net.
Restructuring Charges
Restructuring charges		$ 0.1		$ 2.2

XML

Financial Instruments (Details) - Cash Flow Hedging $ in Millions	9 Months Ended
	Oct. 01, 2016 USD ($)
Financial Instruments
Maximum length of time hedged in cash flow hedge	36 months
Cash Flow Hedge Loss to be Reclassified within Twelve Months	$ 2.0
Foreign exchange contracts
Financial Instruments
Notional amount	1,500.0
Commodity contracts
Financial Instruments
Notional amount	$ 2.3

XML

Financial Instruments - Fair Value (Details) - USD ($) $ in Millions	Oct. 01, 2016	Jan. 02, 2016
Derivatives, Fair Value
Asset	$ 2.1	$ 5.6
Liability	3.1	5.2
Foreign exchange contracts | Other current assets
Derivatives, Fair Value
Asset	2.0	5.6
Foreign exchange contracts | Other current liabilities
Derivatives, Fair Value
Liability	3.1	4.5
Commodity contracts | Other current assets
Derivatives, Fair Value
Asset	$ 0.1
Commodity contracts | Other current liabilities
Derivatives, Fair Value
Liability		$ 0.7

XML

Financial Instruments - Net Gain (Loss) Recognized in Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Fair Value Hedges
Gain (loss) in income	$ (3.0)	$ (17.6)	$ 1.1	$ (12.6)
Foreign exchange contracts | Cost of products sold
Fair Value Hedges
Gain (loss) in income	(0.2)	2.3	1.5	3.3
Foreign exchange contracts | Marketing, general and administrative expense
Fair Value Hedges
Gain (loss) in income	$ (2.8)	$ (19.9)	$ (0.4)	$ (15.9)

XML

Financial Instruments - Gains (Losses) Recognized in AOCI (Details) - Cash Flow Hedging - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Derivative Instruments, Gains (Losses)
Gains (losses) recognized in accumulated other comprehensive loss on derivatives	$ (1.5)	$ 1.0	$ (3.0)	$ 0.7
Foreign exchange contracts
Derivative Instruments, Gains (Losses)
Gains (losses) recognized in accumulated other comprehensive loss on derivatives	(1.3)	2.7	(3.1)	1.2
Commodity contracts
Derivative Instruments, Gains (Losses)
Gains (losses) recognized in accumulated other comprehensive loss on derivatives	$ (0.2)	$ (1.7)	$ 0.1	$ (0.5)

XML

Taxes Based on Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Taxes Based on Income
Income from continuing operations before taxes	$ 128.0	$ 116.1	$ 350.8	$ 317.4
Provision for income taxes	$ 38.9	$ 34.8	$ 92.1	$ 99.5
Effective tax rate (as a percent)	30.40%	30.00%	26.30%	31.30%
Tax expense for adjustments to domestic income taxes	$ 4.8		$ 3.1
Tax benefits from our change in judgment about tax filing positions in certain foreign jurisdictions	1.0		7.1
Tax expense associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries	17.7		26.9
Tax benefit related to effective settlement of uncertain tax positions	11.1		11.1
Tax benefit from the release of valuation allowances against certain deferred tax assets in certain foreign jurisdiction associated with a structural simplification	6.7		6.7
Tax benefits due to decreases in certain tax reserves as a result of closing tax years			3.3	$ 4.2
Tax benefit for adjustments to domestic income taxes		$ 4.2		4.2
Tax benefit from an enacted favorable foreign tax law change				0.9
Net tax benefit related to changes in the effective tax rates in certain foreign municipalities				1.6
Tax expense associated with the tax cost to repatriate non-permanently reinvested 2015 earnings of certain foreign subsidiaries				$ 5.4
Reasonably possible decrease in unrecognized tax benefits from continuing operations during next 12 months	$ 26.0		$ 26.0

XML

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Net income per common share amounts
Income from continuing operations	$ 89.1	$ 81.3	$ 258.7	$ 217.9
Income (loss) from discontinued operations		0.4		(0.6)
Net income available to common shareholders	$ 89.1	$ 81.7	$ 258.7	$ 217.3
Weighted average number of common shares outstanding	89.1	91.5	89.2	91.1
Dilutive shares (additional common shares issuable under stock-based awards)	1.5	1.7	1.7	1.8
Weighted average number of common shares outstanding, assuming dilution	90.6	93.2	90.9	92.9
Net income per common share:
Continuing operations (in dollars per share)	$ 1.00	$ 0.89	$ 2.90	$ 2.39
Net income per common share (in dollars per share)	1.00	0.89	2.90	2.39
Net income (loss) per common share, assuming dilution:
Continuing operations (in dollars per share)	0.98	0.87	2.85	2.35
Discontinued operations (in dollars per share)		0.01		(0.01)
Net income per common share, assuming dilution (in dollars per share)	$ 0.98	$ 0.88	$ 2.85	$ 2.34
Stock-based compensation awards excluded from the computation of net income per common share, assuming dilution	0.1	0.5	0.2	1.0

XML

Comprehensive Income - Changes AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Changes in Accumulated other comprehensive loss (net of tax)
Balance at beginning of the period			$ (683.0)	$ (545.5)
Other comprehensive income (loss) before reclassifications, net of tax			(27.8)	(129.5)
Reclassifications to net income, net of tax			41.8	16.8
Net current-period other comprehensive income (loss), net of tax	$ 19.8	$ (55.6)	14.0	(112.7)
Balance at end of the period	(669.0)	(658.2)	(669.0)	(658.2)
Foreign Currency Translation
Changes in Accumulated other comprehensive loss (net of tax)
Balance at beginning of the period			(158.9)	(19.9)
Other comprehensive income (loss) before reclassifications, net of tax			21.1	(129.6)
Net current-period other comprehensive income (loss), net of tax			21.1	(129.6)
Balance at end of the period	(137.8)	(149.5)	(137.8)	(149.5)
Pension and Other Postretirement Benefits
Changes in Accumulated other comprehensive loss (net of tax)
Balance at beginning of the period			(521.6)	(525.6)
Other comprehensive income (loss) before reclassifications, net of tax			(46.7)	(0.5)
Reclassifications to net income, net of tax			39.8	18.2
Net current-period other comprehensive income (loss), net of tax			(6.9)	17.7
Balance at end of the period	(528.5)	(507.9)	(528.5)	(507.9)
Cash Flow Hedges
Changes in Accumulated other comprehensive loss (net of tax)
Balance at beginning of the period			(2.5)
Other comprehensive income (loss) before reclassifications, net of tax			(2.2)	0.6
Reclassifications to net income, net of tax			2.0	(1.4)
Net current-period other comprehensive income (loss), net of tax			(0.2)	(0.8)
Balance at end of the period	$ (2.7)	$ (0.8)	$ (2.7)	$ (0.8)

XML

Comprehensive Income - Reclassified from AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Amounts reclassified from Accumulated other comprehensive loss
Cost of products sold	$ (1,091.1)	$ (1,062.2)	$ (3,261.4)	$ (3,258.6)
Interest expense	(14.7)	(14.7)	(45.4)	(45.3)
Income from continuing operations before taxes	128.0	116.1	350.8	317.4
Provision for income taxes	(38.9)	(34.8)	(92.1)	(99.5)
Income from continuing operations	89.1	81.3	258.7	217.9
Amounts Reclassified from Accumulated other comprehensive Loss
Amounts reclassified from Accumulated other comprehensive loss
Income from continuing operations	(5.3)	(4.1)	(41.8)	(16.8)
Cash Flow Hedges | Amounts Reclassified from Accumulated other comprehensive Loss
Amounts reclassified from Accumulated other comprehensive loss
Income from continuing operations before taxes	(1.3)	1.2	(2.8)	1.7
Provision for income taxes	0.4	(0.2)	0.8	(0.3)
Income from continuing operations	(0.9)	1.0	(2.0)	1.4
Cash Flow Hedges | Amounts Reclassified from Accumulated other comprehensive Loss | Foreign exchange contracts
Amounts reclassified from Accumulated other comprehensive loss
Cost of products sold	(1.2)	1.4	(2.1)	2.7
Cash Flow Hedges | Amounts Reclassified from Accumulated other comprehensive Loss | Commodity contracts
Amounts reclassified from Accumulated other comprehensive loss
Cost of products sold		(0.1)	(0.6)	(0.9)
Cash Flow Hedges | Amounts Reclassified from Accumulated other comprehensive Loss | Interest rate contracts
Amounts reclassified from Accumulated other comprehensive loss
Interest expense	0.1	0.1	0.1	0.1
Pension and Other Postretirement Benefits | Amounts Reclassified from Accumulated other comprehensive Loss
Amounts reclassified from Accumulated other comprehensive loss
Pension and other postretirement benefits	(6.5)	(7.5)	(60.3)	(26.3)
Provision for income taxes	2.1	2.4	20.5	8.1
Income from continuing operations	$ (4.4)	$ (5.1)	$ (39.8)	$ (18.2)

XML

Comprehensive Income - Income tax expense (benefit) allocated (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Income tax expense (benefit) related to components of other comprehensive income (loss)
Pension and other postretirement benefits	$ 2.0	$ 2.4	$ (4.7)	$ 9.1
Cash flow hedges	(0.1)	(0.1)		(0.2)
Income tax expense (benefit) related to components of other comprehensive income (loss)	$ 1.9	$ 2.3	$ (4.7)	$ 8.9

XML

Fair Value Measurements (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2016	Jan. 02, 2016
Assets
Derivative assets	$ 2.1	$ 5.6
Liabilities
Derivative liabilities	3.1	5.2
Recurring
Assets
Trading securities	18.9	17.9
Derivative assets	2.1	5.6
Bank drafts	15.9	24.8
Liabilities
Derivative liabilities	3.1	5.2
Recurring | Cash and Cash Equivalents
Assets
Trading securities	0.4	0.3
Recurring | Other current assets
Assets
Trading securities	18.5	17.6
Quoted Prices in Active Markets (Level 1) | Recurring
Assets
Trading securities	12.7	11.3
Derivative assets	0.1
Bank drafts	15.9	24.8
Liabilities
Derivative liabilities		0.7
Significant Other Observable Inputs (Level 2) | Recurring
Assets
Trading securities	6.2	6.6
Derivative assets	2.0	5.6
Liabilities
Derivative liabilities	$ 3.1	$ 4.5
Significant Other Unobservable Inputs (Level 3) | Minimum
Liabilities
Discount rate used to value the intangibles	10.00%
Significant Other Unobservable Inputs (Level 3) | Maximum
Liabilities
Discount rate used to value the intangibles	12.00%

XML

Commitments and Contingencies (Details) $ in Millions	9 Months Ended
	Oct. 01, 2016 USD ($) item	Jan. 02, 2016 USD ($)
Environmental
Environmental site contingency number of sites | item	13
Activity related to environmental liabilities
Balance at beginning of year	$ 17.7
Charges (reversals), net	6.1
Payments	(5.9)
Balance at end of year	17.9
Short term environmental liabilities	$ 9.0	$ 7.0

XML

Segment Information - Sales (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Segment Reporting Information
Net sales	$ 1,508.7	$ 1,468.1	$ 4,535.7	$ 4,512.1
Interest expense	(14.7)	(14.7)	(45.4)	(45.3)
Income from continuing operations before taxes	128.0	116.1	350.8	317.4
Other expense, net	4.6	7.0	60.4	49.0
Intersegment
Segment Reporting Information
Net sales	16.9	16.1	51.0	52.4
Pressure-sensitive Materials | Operating segments
Segment Reporting Information
Net sales	1,123.8	1,083.7	3,360.9	3,318.4
Income from continuing operations before taxes	138.7	130.5	425.6	383.2
Other expense, net	2.7	1.1	11.2	13.8
Pressure-sensitive Materials | Intersegment
Segment Reporting Information
Net sales	16.3	14.6	49.0	46.5
Retail Branding and Information Solutions | Operating segments
Segment Reporting Information
Net sales	370.9	366.8	1,127.0	1,138.7
Income from continuing operations before taxes	28.4	25.1	82.8	54.3
Other expense, net	1.5	3.9	7.3	29.4
Retail Branding and Information Solutions | Intersegment
Segment Reporting Information
Net sales	0.5	0.3	1.6	1.5
Vancive Medical Technologies | Operating segments
Segment Reporting Information
Net sales	14.0	17.6	47.8	55.0
Income from continuing operations before taxes	(0.9)	(1.2)	(0.2)	(4.7)
Other expense, net	0.4	1.7	0.5	3.4
Vancive Medical Technologies | Intersegment
Segment Reporting Information
Net sales	0.1	1.2	0.4	4.4
Corporate
Segment Reporting Information
Income from continuing operations before taxes	$ (23.5)	(23.6)	(112.0)	(70.1)
Other expense, net		$ 0.3	$ 41.4	$ 2.4

XML

Segment Information - Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Oct. 01, 2016	Oct. 03, 2015
Restructuring charges
Restructuring charges			$ 14.6
Other items:
Loss from settlement of pension obligations			41.4
Transaction costs	$ 2.0		4.1
Loss (gain) on sale of assets			0.3	$ (1.7)
Loss on sale of product line and related transaction and exit costs		$ 0.2		10.5
Legal settlements		0.2		(0.3)
Other expense, net	4.6	7.0	60.4	49.0
Severance and related costs
Restructuring charges
Restructuring charges	1.9	4.7	10.7	35.0
Asset impairment charges and lease cancellation costs
Restructuring charges
Restructuring charges	$ 0.7	$ 1.9	$ 3.9	$ 5.5